KULR Technology (KULR) 10-Q 12 Aug 24 2024 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2024	Aug. 09, 2024
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2024
Entity File Number	001-40454
Entity Registrant Name	KULR Technology Group, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	81-1004273
Entity Address, Address Line One	4863 Shawline Street
Entity Address, City or Town	San Diego
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92111
City Area Code	408
Local Phone Number	663-5247
Title of 12(b) Security	Common Stock
Trading Symbol	KULR
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		192,989,619
Entity Shell Company	false
Entity Central Index Key	0001662684
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Current Assets:
Cash	$ 1,016,943	$ 1,194,764
Accounts receivable	1,927,203	901,672
Inventory	535,196	1,149,047
Inventory deposits	10,883	27,500
Prepaid expenses and other current assets	375,756	631,361
Total Current Assets	3,865,981	3,904,344
Property and equipment, net	3,774,695	4,698,144
Equipment deposits	1,360,092	1,332,436
Security deposits	98,371	10,228
Intangible assets, net	648,247	719,395
Right-of-use asset, net	1,478,413	129,202
Deferred financing costs, net	166,651	70,607
Total Assets	11,392,450	10,864,356
Current Liabilities:
Accounts payable	1,060,694	2,769,544
Accrued expenses and other current liabilities	3,750,871	3,463,344
Accrued issuable equity	82,116	13,002
Lease liabilities, current portion	487,369	102,186
Notes payable, net of discount, current portion	641,745
Deferred revenue	224,664	551,021
Total Current Liabilities	6,247,459	6,899,097
Lease liabilities, non-current portion	1,059,898
Notes payable, non-current portion	250,000	250,000
Prepaid advance liability, net of discount		5,892,056
Accrued interest		5,899
Total Liabilities	7,557,357	13,047,052
Commitments and contingencies (Note 11)
Stockholders' Equity (Deficit)
Preferred stock
Common stock, $0.0001 par value, 500,000,000 shares authorized; 188,086,914 and 187,955,752 shares issued and outstanding at June 30, 2024, respectively; 134,031,669 and 133,900,507 shares issued and outstanding at December 31, 2023, respectively	18,809	13,403
Additional paid-in capital	81,299,431	64,387,717
Treasury stock, at cost; 131,162 shares held at June 30, 2024 and December 31, 2023.	(296,222)	(296,222)
Accumulated deficit	(77,186,998)	(66,287,594)
Total Stockholders' Equity (Deficit)	3,835,093	(2,182,696)
Total Liabilities and Stockholders' Equity (Deficit)	11,392,450	10,864,356
Series A Preferred Stock
Stockholders' Equity (Deficit)
Preferred stock	73
Series B Convertible Preferred Stock
Stockholders' Equity (Deficit)
Preferred stock
Series C Preferred Stock
Stockholders' Equity (Deficit)
Preferred stock
Series D Preferred Stock
Stockholders' Equity (Deficit)
Preferred stock

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	20,000,000	20,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	188,086,914	134,031,669
Common stock, shares outstanding	187,955,752	133,900,507
Treasury stock, shares	131,162	131,162
Series A Preferred Stock
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	730,000	0
Preferred stock, shares outstanding	730,000	0
Series B Convertible Preferred Stock
Preferred stock, shares authorized	31,000	31,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series C Preferred Stock
Preferred stock, shares authorized	400	400
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series D Preferred Stock
Preferred stock, shares authorized	650	650
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue	$ 2,432,005	$ 2,695,506	$ 4,181,109	$ 4,455,308
Cost of revenue	1,859,377	1,693,318	3,097,692	2,809,732
Gross Profit	572,628	1,002,188	1,083,417	1,645,576
Operating Expenses
Research and development	1,305,186	1,924,138	2,259,811	3,729,153
Selling, general, and administrative	4,594,500	5,158,030	8,807,401	10,257,121
Total Operating Expenses	5,899,686	7,082,168	11,067,212	13,986,274
Loss From Operations	(5,327,058)	(6,079,980)	(9,983,795)	(12,340,698)
Other (Expense) Income
Interest expense	(33,534)	(197,110)	(166,236)	(357,041)
Amortization of debt discount	(527,199)	(214,554)	(702,276)	(460,874)
Loss on debt extinguishment			(31,358)
Change in fair value of accrued issuable equity	(2,737)	156,652	(15,739)	220,760
Total Other Expense, net	(563,470)	(255,012)	(915,609)	(597,155)
Net Loss	$ (5,890,528)	$ (6,334,992)	$ (10,899,404)	$ (12,937,853)
Net Loss Per Share - Basic (in dollars per share)	$ (0.03)	$ (0.05)	$ (0.07)	$ (0.11)
Net Loss Per Share - Diluted (in dollars per share)	$ (0.03)	$ (0.05)	$ (0.07)	$ (0.11)
Weighted Average Number of Common Shares Outstanding - Basic (in shares)	181,467,264	115,380,700	161,914,634	114,133,873
Weighted Average Number of Common Shares Outstanding - Diluted (in shares)	181,467,264	115,380,700	161,914,634	114,133,873

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)		Series A Convertible Preferred Stock Convertible Preferred Stock	Common Stock	Additional Paid-In Capital Restricted common stock	Additional Paid-In Capital Stock options	Additional Paid-In Capital	Treasury Stock	Accumulated Deficit	Restricted common stock	Stock options	Total
Treasury stock, shares							131,162
Balance at beginning at Dec. 31, 2022			$ 11,320			$ 53,372,673	$ (296,222)	$ (42,594,038)			$ 10,493,733
Balance (in shares) at Dec. 31, 2022			113,202,749
Common stock issued for services (in shares)			5,500
Common stock issued for services			$ 1			6,819					6,820
Common stock issued for the repayment of prepaid advance liability and related interest accrual (in shares)			3,153,036
Common stock issued for the repayment of prepaid advance liability and related interest accrual			$ 315			3,750,653					3,750,968
Shares repurchased for payroll taxes and canceled (in shares)			(175,000)
Shares repurchased for payroll taxes and canceled			$ (17)			(229,232)					(229,249)
Restricted stock awards granted (in shares)			1,848,508
Restricted stock awards granted			$ 185			(185)
Unvested restricted stock awards canceled (in shares)			(75,000)
Unvested restricted stock awards canceled			$ (8)			8
Amortization				$ 765,100	$ 40,605				$ 765,100	$ 40,605
Net Income (Loss)								(6,602,861)			(6,602,861)
Balance (in shares) at Mar. 31, 2023			117,959,793
Balance at ending at Mar. 31, 2023			$ 11,796			57,706,441	(296,222)	(49,196,899)			8,225,116
Balance at beginning at Dec. 31, 2022			$ 11,320			53,372,673	(296,222)	(42,594,038)			10,493,733
Balance (in shares) at Dec. 31, 2022			113,202,749
Common stock issued for the repayment of prepaid advance liability and related interest accrual pursuant to Advance Notices											4,466,626
Net Income (Loss)											(12,937,853)
Balance (in shares) at Jun. 30, 2023			118,885,728
Balance at ending at Jun. 30, 2023			$ 11,889			59,289,857	$ (296,222)	(55,531,891)			3,473,633
Treasury stock, shares							131,162
Balance at beginning at Mar. 31, 2023			$ 11,796			57,706,441	$ (296,222)	(49,196,899)			8,225,116
Balance (in shares) at Mar. 31, 2023			117,959,793
Common stock issued for the repayment of prepaid advance liability and related interest accrual (in shares)			925,935
Common stock issued for the repayment of prepaid advance liability and related interest accrual			$ 93			715,565					715,658
Amortization				823,540	44,311				823,540	44,311
Net Income (Loss)								(6,334,992)			(6,334,992)
Balance (in shares) at Jun. 30, 2023			118,885,728
Balance at ending at Jun. 30, 2023			$ 11,889			59,289,857	$ (296,222)	(55,531,891)			$ 3,473,633
Treasury stock, shares							131,162
Treasury stock, shares							131,162				131,162
Balance at beginning at Dec. 31, 2023			$ 13,403			64,387,717	$ (296,222)	(66,287,594)			$ (2,182,696)
Balance (in shares) at Dec. 31, 2023			134,031,669
Preferred stock issued for no consideration (in shares)		730,000
Preferred stock issued for no consideration		$ 73				(73)
Common stock issued for the repayment of prepaid advance liability and related interest accrual pursuant to Advance Notices ( in shares)	[1]		21,798,830
Common stock issued for the repayment of prepaid advance liability and related interest accrual pursuant to Advance Notices	[1]		$ 2,180			6,052,650					6,054,830
Common stock issued for cash pursuant to Advance Notices (in shares)	[2]		19,228,351
Common stock issued for cash pursuant to Advance Notices	[2]		$ 1,923			2,904,490					2,906,413
Restricted stock awards exchanged for restricted stock units (in shares)			2,168,508
Restricted stock awards exchanged for restricted stock units			$ (217)			217
Restricted stock units vested (in shares)			384,627
Restricted stock units vested			$ 38			(38)
Common stock issued for services (in shares)			35,500
Common stock issued for services			$ 4			6,386					6,390
Amortization				781,496	32,041				781,496	32,041
Net Income (Loss)								(5,008,876)			(5,008,876)
Balance (in shares) at Mar. 31, 2024		730,000	173,310,469
Balance at ending at Mar. 31, 2024		$ 73	$ 17,331			74,164,886	(296,222)	(71,296,470)			2,589,598
Balance at beginning at Dec. 31, 2023			$ 13,403			64,387,717	(296,222)	(66,287,594)			(2,182,696)
Balance (in shares) at Dec. 31, 2023			134,031,669
Common stock issued for the repayment of prepaid advance liability and related interest accrual pursuant to Advance Notices											6,068,407
Net Income (Loss)											(10,899,404)
Balance (in shares) at Jun. 30, 2024		730,000	188,086,914
Balance at ending at Jun. 30, 2024		$ 73	$ 18,809			81,299,431	$ (296,222)	(77,186,998)			3,835,093
Treasury stock, shares							131,162
Balance at beginning at Mar. 31, 2024		$ 73	$ 17,331			74,164,886	$ (296,222)	(71,296,470)			2,589,598
Balance (in shares) at Mar. 31, 2024		730,000	173,310,469
Common stock issued for cash pursuant to Advance Notices (in shares)	[3]		14,632,295
Common stock issued for cash pursuant to Advance Notices	[3]		$ 1,464			6,140,043					6,141,507
Warrants issued in connection with note payable						112,863					112,863
Restricted stock units vested (in shares)			70,000
Restricted stock units vested			$ 7			(7)
Common stock issued for services (in shares)			74,150
Common stock issued for services			$ 7			38,143					38,150
Amortization				$ 814,338	$ 29,165				$ 814,338	$ 29,165
Net Income (Loss)								(5,890,528)			(5,890,528)
Balance (in shares) at Jun. 30, 2024		730,000	188,086,914
Balance at ending at Jun. 30, 2024		$ 73	$ 18,809			$ 81,299,431	$ (296,222)	$ (77,186,998)			$ 3,835,093
Treasury stock, shares							131,162				131,162
[1]Represents gross proceeds of $6,068,407, less issuance costs of $13,577.[2]Represents gross proceeds of $2,910,651, less issuance costs of $4,238.[3]Represents gross proceeds of $6,194,299, less issuance costs of $52,792.

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)	3 Months Ended
	Mar. 31, 2024 USD ($)
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)
Proceeds from issuance of common stock for repayment of prepaid advance	$ 6,068,407
Issuance costs on equity financing	13,577
Proceeds from common stock issued for cash pursuant to Advance Notices	2,910,651
Equity financing, issuance costs	$ 4,238

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
Cash Flows From Operating Activities:
Net Income (Loss)		$ (10,899,404)	$ (12,937,853)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount		702,276	460,874
Non-cash lease expense		226,708	123,749
Loss on debt extinguishment		31,358
Depreciation and amortization expense		1,218,779	862,086
Change in fair value of accrued issuable equity		15,739	(220,760)
Stock-based compensation		1,754,955	1,966,929
Loss on disposal of property and equipment		20,866
Changes in operating assets and liabilities:
Accounts receivable		(1,025,531)	(1,046,532)
Inventory		613,851	581,634
Inventory deposits		16,617	240,532
Prepaid expenses and other current assets		255,605	(117,648)
Security deposits		(88,143)	(5,095)
Accounts payable		(1,768,098)	(643,578)
Accrued expenses and other current liabilities		183,164	1,029,513
Lease liabilities		(130,838)	(130,679)
Deferred revenue		(326,357)	(21,859)
Total Adjustments		1,700,951	3,079,166
Net Cash Used In Operating Activities		(9,198,453)	(9,858,687)
Cash Flows From Investing Activities:
Equipment deposits		(27,656)	(567,332)
Purchases of property and equipment		(135,367)	(192,644)
Acquisition of intangible assets			(135,000)
Net Cash Used In Investing Activities		(163,023)	(894,976)
Cash Flows from Financing Activities:
Proceeds from the SEPA		9,104,950
Proceeds from prepaid advance liability			2,000,000
Issuance costs on prepaid advance liability			(30,000)
Net proceeds from notes payable	[1]	1,730,000
Issuance costs on notes payable		(126,100)
Repayments of notes payable		(1,525,195)
Repurchase of common stock			(229,249)
Net Cash Provided By Financing Activities		9,183,655	1,740,751
Net Decrease In Cash		(177,821)	(9,012,912)
Cash - Beginning of Period		1,194,764	10,333,563
Cash - End of Period		1,016,943	1,320,651
Non-cash investing and financing activities:
Right-of-use asset for lease liability		1,575,919	51,154
Restricted stock units vested		45
Original issue discount on indebtedness		579,200	105,263
Common stock issued in satisfaction of prepaid advance liability and interest		6,068,407	4,466,626
Deposits applied to purchases of property and equipment			2,716,057
Capital Expenditures Incurred but Not yet Paid		109,681	166,663
Additions to property and equipment included in accounts payable and accrued expenses		109,681	166,663
Equipment deposits included in accounts payable			$ 171,444
Deferred financing costs charged to additional paid-in capital		70,607
Value of warrants issued in connection with notes payable		112,863
Accrued deferred financing costs		166,651
Preferred shares issued for no consideration		73
Restricted Stock Awards Conversion
Non-cash investing and financing activities:
Restricted stock awards converted to restricted stock units		$ 217
[1]Face value of $2,309,200, less $579,200 original issue discount.

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - Promissory Note	6 Months Ended
	Jun. 30, 2024 USD ($)
Initial principal amount	$ 2,309,200
Original issuance discount	$ 579,200

ORGANIZATION, NATURE OF OPERATI

ORGANIZATION, NATURE OF OPERATIONS AND BASIS OF PRESENTATION	6 Months Ended
	Jun. 30, 2024
ORGANIZATION, NATURE OF OPERATIONS AND BASIS OF PRESENTATION
ORGANIZATION, NATURE OF OPERATIONS AND BASIS OF PRESENTATION	NOTE 1 ORGANIZATION, NATURE OF OPERATIONS AND BASIS OF PRESENTATION Organization and Operations KULR Technology Group, Inc., through its wholly-owned subsidiary, KULR Technology Corporation (collectively referred to as “KULR” or the “Company”), develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components across a range of applications. Currently, the Company is focused on targeting both high performance aerospace and Department of Defense (“DOD”) applications, such as space exploration, satellite communications, and underwater vehicles, and applying them to mass market commercial applications, such as lithium-ion battery energy storage, electric vehicles, fifth generation (“5G”) communication, cloud computer infrastructure, consumer and industrial devices. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the unaudited condensed consolidated financial statements of the Company as of June 30, 2024, and for the three and six months ended June 30, 2024 and 2023. The results of operations for the three and six months ended June 30, 2024, are not necessarily indicative of the operating results for the full year ending December 31, 2024, or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and related disclosures as of December 31, 2023 and for the year then ended, which were filed with the Securities and Exchange Commission (“SEC”) on Form 10-K on April 12, 2024. The accompanying condensed consolidated balance sheet as of December 31, 2023, has been derived from the audited financial statements included in the Form 10-K.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Since the date of the Annual Report on Form 10-K for the year ended December 31, 2023, there have been no material changes to the Company’s significant accounting policies, except as disclosed in this note. Going Concern and Management’s Liquidity Plans As of June 30, 2024, the Company had cash of $1,016,943 and a working capital deficit of $2,381,478. For the six months ended June 30, 2024, the Company incurred a net loss of $10,899,404 and used cash in operating activities of $9,198,453. The Company’s primary source of liquidity has historically been cash generated from equity and debt offerings along with cash flows from revenue. Under ASC Subtopic 205-40, Presentation of Financial Statements—Going Concern (“ASC 205-40”), the Company has the responsibility to evaluate whether conditions and/or events raise substantial doubt about its ability to meet future financial obligations as they become due within one year after the date that these financial statements are issued. The accompanying condensed consolidated financial statements have been prepared on the basis that we will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. However, since the Company’s inception, we have had a history of recurring net losses from operations, recurring use of cash in operating activities and working capital deficits. Future cash requirements for our current liabilities include $4,811,565 for accounts payable and accrued expenses, $784,006 for secured promissory notes (see Note 9 – Notes Payable) and $487,369 for future payments under operating leases. Future cash requirements for long-term liabilities include $1,059,898 for future payments under operating leases and $250,000 for unsecured promissory notes. On December 20, 2023, the Company received a notice of noncompliance from NYSE Regulation (“NYSE”) stating it is not in compliance with Section 1003(a)(iii) in the NYSE American Company Guide (the “Company Guide”) since the Company reported stockholders’ equity of $1,200,172 at September 30, 2023, and losses from continuing operations and/or net losses in its five most recent fiscal years. On February 12, 2024, the Company received a second notice letter from NYSE stating it is not in compliance with Section 1003 (f)(v) of the Company guide since the Company’s securities were trading at an average of less than $0.20 per share for 30 days. On March 5, 2024, the Company received a notification from the NYSE that the Company’s plan to regain compliance with Section 1003 (a)(iii) of the Company Guide was accepted and so long as the Company meets its interim objectives, the Company will have until June 20, 2025, to regain compliance with the minimum stockholders’ equity requirement. On May 1, 2024, the Company received a notification from the NYSE stating that the Company had regained compliance with Section 1003 (f)(v) of the Company Guide, given the increase in the trading price of the Company’s securities. The factors above raise substantial doubt about the Company’s ability to meet its obligations as they become due within the twelve months from the date these condensed consolidated financial statements are issued. Management’s plans to mitigate the factors which raise substantial doubt include (i) revenue growth, (ii) reducing operating expenses through careful cost management, and (iii) raising additional funds through future financings. On July 3, 2024, the Company entered into an At the Market Offering agreement (the “ATM”) with an agent (the “Agent”), pursuant to which the Company may, from time to time, sell shares of common stock having an aggregate offering price of up to $20,000,000 in “at the market” offerings through or to the Agent. Sales of the shares of common stock, if any, will be made at prevailing market prices at the time of the sale, or as otherwise agreed with the Agent. The Agent will receive a commission from the Company of 3% of the gross proceeds of any shares of common stock sold under the Sales Agreement. During the period from July 3, 2024, through August 9, 2024, the Company issued a total of 4,953,867 shares of common stock pursuant to the Sales Agreement for aggregate proceeds of $1,416,940. See Note 12 – Subsequent Events – At the Market Offering for additional information. The Company’s ability to continue as a going concern is dependent upon its ability to successfully execute the aforementioned initiatives. There is no assurance that the amount of funds the Company might raise will enable the Company to complete its development initiatives or attain profitable operations. The aforementioned factors indicate that management’s plans do not alleviate the substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements. These unaudited condensed consolidated financial statements do not include any adjustments relating to the recoverability of assets and the amounts and classification of liabilities that may be necessary should the Company be unable to continue as a going concern. Use of Estimates Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the financial statements. The Company’s significant estimates used in these unaudited condensed consolidated financial statements include, but are not limited to, fair value calculations for intangible assets, equity securities, stock-based compensation and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates. Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consisted primarily of cash and accounts receivable. The Company’s concentrations of credit risk also include concentrations from key customers and vendors. Cash Concentrations A significant portion of the Company’s cash is held at one major financial institution. The Company has not experienced any losses in such accounts. Cash held in US bank institutions is currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 at each institution. There were uninsured balances of $516,943 and $694,764 as of June 30, 2024 and December 31, 2023, respectively. Customer and Revenue Concentrations The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, or whose accounts receivable balances individually represented 10% or more of the Company’s total accounts receivable, as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Revenue ​ Accounts Receivable ​ ​ For the Three Months Ended ​ For the Six Months Ended ​ As of ​ As of ​ ​ June 30, ​ June 30, ​ June 30, December 31, ​ 2024 2023 2024 2023 2024 ​ 2023 Customer A 31 % * ​ 18 % * ​ 43 % * ​ Customer B 19 % * ​ 11 % * ​ 24 % * ​ Customer C 10 % * ​ * ​ * ​ * ​ 52 % Customer D ​ * ​ 46 % * ​ 63 % * ​ 20 % Customer E ​ * ​ 19 % * ​ * ​ * ​ 14 % Customer F ​ * ​ 17 % * ​ 10 % * ​ * ​ Customer G ​ * ​ * ​ 17 % * ​ * ​ * ​ Total 60 % 82 % 46 % 73 % 67 % 86 % * Less than 10% ​ There is no assurance the Company will continue to receive significant revenue from any of these customers. Any reduction or delay in operating activity from any of the Company’s significant customers, or a delay or default in payment by any significant customer, or termination of agreements with significant customers, could materially harm the Company’s business and prospects. As a result of the Company’s significant customer concentrations, its gross profit and results from operations could fluctuate significantly due to changes in political, environmental, or economic conditions, or the loss of, reduction of business from, or less favorable terms with any of the Company’s significant customers. Vendor Concentrations The Company had vendors whose purchases of inventory individually represented 10% or more of the Company’s total purchases of inventory, for the three and six months ended June 30, 2024 and 2023, as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended For the Six Months Ended ​ ​ June 30, June 30, ​ ​ 2024 2023 2024 2023 ​ Vendor A 19 % * ​ 29 % * ​ Vendor B 19 % * ​ 28 % * ​ Vendor C ​ * ​ 16 % * ​ 14 % Vendor D * ​ 10 % * ​ * ​ ​ 38 % 26 % 57 % 14 % * Less than 10% Accounts Receivable Accounts receivable are carried at their contractual amounts, less an estimate for credit losses. As of June 30, 2024 and December 31, 2023, no allowances for credit losses were determined to be necessary. Management estimates the allowance for credit losses based on existing economic conditions, the financial conditions of the customers, and the amount and age of past due accounts. Receivables are considered past due if full payment is not received by the contractual due date. Past due accounts are generally written off against the allowance for credit losses only after all collection attempts have been exhausted. Inventory The Company capitalizes inventory costs associated with products when future commercialization is considered probable, and a future economic benefit is expected to be realized. These costs consist of finished goods, raw materials, manufacturing-related costs, transportation and freight, and other indirect overhead costs. Inventory is comprised of carbon fiber velvet (“CFV”) thermal interface solutions and internal short circuit batteries, which are available for sale, as well as raw materials and work in process related primarily to the manufacture of safe cases. Safe cases provide a safe and cost-effective solution to commercially store and transport lithium batteries and mitigate the impacts of cell-to-cell thermal runway propagation. Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out method. The cost of inventory that is sold to third parties is included within cost of revenue and the cost of inventory that is given as samples is included within operating expenses. The Company periodically reviews for slow-moving, excess or obsolete inventories. Products that are determined to be obsolete, if any, are written down to net realizable value. On occasion, the Company pays for inventory prior to receiving the goods. These payments are recorded as inventory deposits until the goods are received and these costs are included in the current asset section of the condensed consolidated balance sheets. As of June 30, 2024 and December 31, 2023, inventory deposits were $10,883 and $27,500 , respectively. Finished goods inventory is held on-site at the San Diego, California and Webster, Texas locations. Certain raw materials are held off-site with certain contract manufacturers. Inventory at June 30, 2024 and December 31, 2023 was comprised of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, December 31, ​ ​ 2024 ​ 2023 Raw materials ​ $ 409,168 ​ $ 322,111 Finished goods ​ 126,028 ​ 826,936 Total inventory ​ $ 535,196 ​ $ 1,149,047 ​ Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The following five steps are applied to achieve that core principle: ● Step 1: Identify the contract with the customer; ● Step 2: Identify the performance obligations in the contract; ● Step 3: Determine the transaction price; ● Step 4: Allocate the transaction price to the performance obligations in the contract; and ● Step 5: Recognize revenue when the company satisfies a performance obligation. The Company recognizes revenue primarily from the following different types of contracts: ● Product sales – Revenue is recognized at the point in time the customer obtains control of the goods and the Company satisfies its performance obligation, which is generally at the time it ships the product to the customer. ● Contract services – Revenue is recognized pursuant to the terms of each individual contract when the Company satisfies the respective performance obligations, which could be recognized at a point in time or over the term of the contract. Contract services revenue that is recognized over time, may be recognized using the input method, based on labor hours expended, or using the output method based on milestones achieved, depending on the contract. The following table summarizes the Company’s revenue recognized by type of contract in its condensed consolidated statements of operations: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Six Months Ended ​ ​ June 30, ​ June 30, ​ 2024 2023 2024 2023 Revenue Recognized at a Point in Time: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Product sales ​ $ 1,134,769 ​ $ 1,957,370 ​ $ 1,749,862 ​ $ 3,586,628 Contract services ​ ​ 1,185,236 ​ ​ 270,476 ​ ​ 1,701,707 ​ ​ 401,020 Total ​ ​ 2,320,005 ​ ​ 2,227,846 ​ ​ 3,451,569 ​ ​ 3,987,648 Revenue Recognized Over Time: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Contract services ​ 112,000 ​ 467,660 ​ 729,540 ​ 467,660 Total Revenue ​ $ 2,432,005 ​ $ 2,695,506 ​ $ 4,181,109 ​ $ 4,455,308 ​ Net Loss Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common and dilutive common-equivalent shares outstanding during each period. ​ The following table presents the computation of basic and diluted net loss per common share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended For the Six Months Ended ​ ​ June 30, ​ June 30, ​ ​ 2024 2023 ​ 2024 2023 Numerator: ​ ​ ​ ​ Net loss ​ $ (5,890,528) ​ $ (6,334,992) ​ $ (10,899,404) ​ $ (12,937,853) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator (weighted average quantities): ​ ​ ​ ​ ​ ​ ​ ​ Common shares issued ​ 182,151,812 ​ 118,617,860 ​ 162,824,020 ​ 116,846,331 Less: Treasury shares purchased ​ (131,162) ​ (131,162) ​ (131,162) ​ (131,162) Less: Unvested restricted shares ​ (690,248) ​ (3,240,679) ​ (880,871) ​ ​ (2,708,655) Add: Accrued issuable equity ​ ​ 136,862 ​ ​ 134,681 ​ ​ 102,647 ​ ​ 127,359 Denominator for basic and diluted net loss per share ​ ​ 181,467,264 ​ ​ 115,380,700 ​ ​ 161,914,634 ​ ​ 114,133,873 ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net loss per common share ​ $ (0.03) ​ $ (0.05) ​ $ (0.07) ​ $ (0.11) ​ The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive: ​ ​ ​ ​ ​ ​ ​ ​ June 30, ​ 2024 2023 Prepaid advance liability (1) ​ — ​ 10,168,469 Unvested restricted stock awards ​ 650,000 ​ 3,116,008 Unvested restricted stock units ​ 4,825,111 ​ 3,000,000 Options 702,716 795,216 Warrants ​ 2,714,587 ​ 2,524,410 Total 8,892,414 19,604,103 (1) Operating Leases The Company leases properties under operating leases. For leases in effect upon adoption of Accounting Standards Update (“ASU”) 2016-02, “Leases (Topic 842)” at January 1, 2020, and for any leases commencing thereafter, the Company recognizes a liability to make lease payments, the “lease liability”, and an asset representing the right to use the underlying asset during the lease term, the “right-of-use asset”. The lease liability is measured at the present value of the remaining lease payments, discounted at the Company’s incremental borrowing rate. The right-of-use asset is measured at the amount of the lease liability adjusted for any lease incentives received, any cumulative prepaid or accrued rent if the lease payments are uneven throughout the lease term, any unamortized initial direct costs, and any impairment of the right-of-use-asset. Operating lease expense consists of a single lease cost calculated so that the remaining cost of the lease is allocated over the remaining lease term on a straight-line basis, variable lease payments not included in the lease liability, and any impairment of the right-of-use asset. The Company elected the accounting policy to include both the lease and non-lease components of the agreements as a single component and account for them as a lease. Reclassifications Certain prior period balances have been reclassified to conform to the current period presentation. These reclassifications have no effect on previously reported results of operations or loss per share. Subsequent Events The Company has evaluated subsequent events through the date on which these unaudited condensed consolidated financial statements were issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, except as disclosed in Note 12 – Subsequent Events. Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (the “FASB”) FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” These amendments require a public entity to disclose significant segment expenses and other segment items on an annual and interim basis and to provide in interim periods all disclosures about a reportable segment’s profit or loss and assets that are currently required annually. Public entities with a single reporting segment are required to provide both the new disclosures and all of the existing disclosures required under ASC 280. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating any new disclosures that may be required upon adoption of ASU 2023-07. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The amendments in ASU 2023 – 09 are effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating any new disclosures that may be required upon adoption of ASU 2023–09. Recently Adopted Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity; Own Equity (“ASU 2020-06”), as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. Among other changes, the new guidance removes from GAAP separation models for convertible debt that require the convertible debt to be separated into a debt and equity component, unless the conversion feature is required to be bifurcated and accounted for as a derivative or the debt is issued at a substantial premium. As a result, after adopting the guidance, entities will no longer separately present such embedded conversion features in equity and will instead account for the convertible debt wholly as debt. The new guidance also requires use of the “if-converted” method when calculating the dilutive impact of convertible debt on earnings per share, which is consistent with the Company’s current accounting treatment under the current guidance. The guidance is effective for the Company in financial statements issued for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted, but only at the beginning of the fiscal year. The Company adopted this ASU on January 1, 2024, and the adoption did not have a material impact on its condensed consolidated financial statements.

PREPAID EXPENSES AND OTHER CURR

PREPAID EXPENSES AND OTHER CURRENT ASSETS	6 Months Ended
	Jun. 30, 2024
PREPAID EXPENSES AND OTHER CURRENT ASSETS
PREPAID EXPENSES AND OTHER CURRENT ASSETS	NOTE 3 – PREPAID EXPENSES AND OTHER CURRENT ASSETS As of June 30, 2024 and December 31, 2023, prepaid expenses and other current assets consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, December 31, ​ 2024 2023 Compensation costs ​ $ 225,000 ​ $ 375,000 Dues and subscriptions ​ ​ 55,189 ​ ​ 50,689 Deferred expenses ​ ​ 53,247 ​ ​ 59,089 Professional fees ​ ​ 13,506 ​ ​ 24,125 Vendor receivables ​ ​ 7,389 ​ ​ 1,995 Security deposits ​ ​ 5,095 ​ ​ 55,308 Insurance ​ ​ 116 ​ ​ 32,606 Conferences and seminars ​ ​ — ​ ​ 19,338 Investor relations ​ ​ — ​ ​ 1,512 Other ​ ​ 16,214 ​ ​ 11,699 Total prepaid expenses and other current assets ​ $ 375,756 ​ $ 631,361 ​

ACCRUED EXPENSES AND OTHER CURR

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	6 Months Ended
	Jun. 30, 2024
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	NOTE 4 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES As of June 30, 2024 and December 31, 2023, accrued expenses and other current liabilities consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, ​ December 31, ​ 2024 2023 Professional fees ​ $ 2,094,938 ​ $ 1,875,000 Research and development ​ ​ 441,192 ​ ​ 441,192 Payroll and vacation ​ ​ 412,974 ​ ​ 504,748 Inventory purchases ​ 291,925 ​ ​ 145,949 Sales tax payable ​ ​ 110,473 ​ ​ 46,901 Legal fees ​ 110,000 ​ ​ 117,640 Royalties ​ ​ 58,841 ​ ​ 17,505 Board compensation ​ 37,500 ​ ​ 23,750 Securities fees ​ 37,500 ​ ​ — Refund due to customer ​ — ​ ​ 171,960 Cost of sales ​ ​ — ​ ​ 28,663 Other ​ ​ 155,528 ​ ​ 90,036 Total accrued expenses and other current liabilities ​ 3,750,871 ​ ​ 3,463,344 Add: Accrued interest, non-current ​ ​ — ​ ​ 5,899 Total accrued expenses and other liabilities ​ $ 3,750,871 ​ $ 3,469,243 ​

ACCRUED ISSUABLE EQUITY

ACCRUED ISSUABLE EQUITY	6 Months Ended
	Jun. 30, 2024
ACCRUED ISSUABLE EQUITY
ACCRUED ISSUABLE EQUITY	NOTE 5 – ACCRUED ISSUABLE EQUITY A summary of the accrued issuable equity activity during the six months ended June 30, 2024 is presented below: ​ ​ ​ ​ ​ ​ ​ For the Six Months Ended ​ June 30, 2024 Beginning balance at January 1, 2024 ​ $ 13,002 Additions ​ ​ 53,375 Mark-to-market ​ ​ 15,739 Fair value at June 30, 2024 ​ $ 82,116 ​ During the six months ended June 30, 2024, the Company became obligated to issue a fixed number of shares of common stock of the Company as consideration for services provided by an employee pursuant to a contractual arrangement previously entered into with the employee. On the date the contract was entered into, the estimated fair value of the shares to be issued was an aggregate of $53,375 based on the quoted market prices of the shares. The Company recorded losses in the aggregate amount of $2,737 and $15,739 during the three and six months ended June 30, 2024, respectively, and recorded gains in the aggregate amount of $156,652 and $220,760 during the three and six months ended June 30, 2023, respectively, related to changes in the fair value of accrued issuable equity (see Note 10 – Stockholders’ Equity, Stock-Based Compensation

PREPAID ADVANCE LIABILITY, NET

PREPAID ADVANCE LIABILITY, NET OF DISCOUNT	6 Months Ended
	Jun. 30, 2024
PREPAID ADVANCE LIABILITY, NET OF DISCOUNT
PREPAID ADVANCE LIABILITY, NET OF DISCOUNT	NOTE 6 – PREPAID ADVANCE LIABILITY, NET OF DISCOUNT ​ The Company’s prepaid advance liability, net of discount, consists of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross Amount of Less: Prepaid Advance ​ ​ Prepaid Advance ​ Debt ​ Liability, ​ ​ Liability ​ Discount ​ net of discount Balance, January 1, 2024 ​ $ 5,918,430 ​ $ (26,374) ​ $ 5,892,056 Repayments pursuant to Advance Notices ​ (5,918,430) ​ — ​ (5,918,430) Amortization of debt discount ​ — ​ 26,374 ​ 26,374 Balance, June 30, 2024 ​ $ — ​ $ — ​ $ — ​ On January 9, 2024, the Company entered into a letter agreement with Yorkville to defer the Company’s December 31, 2023 (the “December Payment”) payment of $2,000,000 plus accrued interest and a 5% cash payment premium until February 29, 2024. On February 13, 2024, the Company and Yorkville entered into another agreement to extend all payment due dates and defer all payment obligations to December 31, 2024. During the six months ended June 30, 2024, the Company issued 55,659,476 shares of common stock pursuant to SEPA Advance Notices submitted by the Company to Yorkville for aggregate proceeds of $15,173,357. Of the shares issued pursuant to the SEPA Advance Notices, 21,798,830 shares valued at $6,068,407 were issued in satisfaction of $5,918,430 of principal and $118,619 of accrued interest owed in connection with the Company’s prepaid advance liability. The Company recorded $31,358 in extinguishment loss and charged $13,577 of deferred financing costs to additional paid-in capital in connection with the shares issued in satisfaction of the prepaid advance liability. As of June 30, 2024, the Prepaid Advance Liability and the related accrued interest has been repaid in full and the SEPA has been terminated. See Note 10 – Stockholders’ Equity (Deficit) - Standby Equity Purchase Agreement (“SEPA”) and Supplemental SEPA for additional information. The remaining 33,860,646 shares issued pursuant to the SEPA Advance Notices were issued for cash proceeds of $9,104,950, which was used to fund the operations of the Company. Deferred financing costs in the amount of $57,030 were charged to additional paid-in capital in connection with the shares issued for cash.

LEASES

LEASES	6 Months Ended
	Jun. 30, 2024
LEASES
LEASES	NOTE 7 – LEASES On January 31, 2024, the initial lease for Webster, Texas dated January 18, 2023, expired. On January 27, 2024, the Company entered into a lease agreement for new office space in Webster, Texas. The initial lease term is 63 months. The lease contains an option to renew for an additional 36 months, which is not reasonably certain to be exercised and therefore is not included in the measurement of the ROU asset and lease liability. Monthly rental payments under the new lease are $33,086, which is comprised of $21,950 of base rent and $11,136 of common area maintenance fees. No cash payments are due for the first three months of the lease. The Company determined that the value of the lease liability and related right-of-use asset at inception was $1,085,497, using an incremental borrowing rate of 10%. The Company paid a security deposit of $37,930 in connection with the Webster lease agreement which is recorded within the security deposits section of the balance sheet as of June 30, 2024. The Company also leases office space at 4863 Shawline Street, San Diego, CA 92111, pursuant to an operating lease which expired May 31, 2024 (the “San Diego Lease”). On January 25, 2024, the Company entered into an amendment to the lease dated April 5, 2021, for the facility located at 4863 Shawline Street, San Diego, CA 92111 (the “First Renewal”). Pursuant to the amendment, the lease is extended for a period of eighteen months commencing June 1, 2024, and terminating November 30, 2025. Monthly rental payments under the amendment are $29,337. The Company determined that the value of the modified lease liability and related right-of-use asset to be $490,422, using an incremental borrowing rate of 10%. As of June 30, 2024, the Company does not have any financing leases. During the three and six months ended June 30, 2024, operating lease expense was $111,591 and $226,708, respectively. During the three and six months ended June 30, 2023, operating lease expense was $65,873 and $131,746, respectively. Maturities of lease liabilities as of June 30, 2024, were as follows: ​ ​ ​ ​ ​ Year ​ July 1, 2024 through December 31, 2024 ​ $ 307,722 2025 ​ ​ 601,196 2026 ​ ​ 280,228 2027 ​ 289,008 2028 ​ ​ 297,788 Thereafter ​ ​ 101,703 Total future minimum lease payments ​ 1,877,645 Less: amount representing imputed interest ​ ​ (330,378) Present value of lease liabilities ​ ​ 1,547,267 Less: current portion ​ ​ (487,369) Lease liabilities, non current portion ​ $ 1,059,898 ​ Supplemental cash flow information related to the lease was as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Six Months Ended ​ June 30, ​ ​ ​ 2024 2023 ​ Cash paid for amounts included in the measurement of lease liabilities: ​ ​ ​ ​ ​ ​ ​ Operating cash flows used in operating activities ​ $ 130,838 ​ $ 130,678 ​ Right-of-use assets obtained in exchange for lease obligations ​ ​ ​ ​ ​ ​ ​ Operating leases ​ $ 1,575,919 ​ $ 51,154 ​ Weighted Average Remaining Lease Term (Years) ​ ​ ​ ​ ​ ​ ​ Operating leases ​ ​ 3.77 years ​ 0.88 years Weighted Average Discount Rate ​ ​ ​ ​ ​ ​ ​ Operating leases ​ ​ 10.0 % ​ 5.0 % ​

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2024
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 8 – RELATED PARTY TRANSACTIONS During the three and six months ended June 30, 2023, the Company recognized expenses of $16,755 and $27,210, respectively, for consulting services provided by the father of the company’s Chief Technology Officer, which are included within selling, general and administrative expenses on the unaudited condensed consolidated statements of operations. For the three and six months ended June 30, 2024, there were no expenses with related parties. As of June 30, 2024 and December 31, 2023, the Company did not have any accounts payable outstanding with related parties.

NOTES PAYABLE

NOTES PAYABLE	6 Months Ended
	Jun. 30, 2024
NOTES PAYABLE
NOTES PAYABLE	NOTE 9-NOTES PAYABLE A summary of the notes payable activity during the six months ended June 30, 2024 is presented below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Notes Debt ​ ​ ​ ​ Payable ​ Discount ​ Total Outstanding, January 1, 2024 ​ $ — ​ $ — ​ — Proceeds from merchant cash advances ​ 1,609,200 ​ (529,200) ​ 1,080,000 Proceeds from promissory notes ​ ​ 700,000 ​ ​ (50,000) ​ ​ 650,000 Issuance costs paid in cash ​ — ​ (53,200) ​ (53,200) Issuance costs to be paid in equity ​ — ​ ​ (112,863) ​ (112,863) Underwriting fees paid in cash ​ — ​ ​ (72,900) ​ (72,900) Repayments in cash ​ (1,525,195) ​ — ​ (1,525,195) Amortization of debt discount ​ — ​ 675,902 ​ 675,902 Notes payable, current-portion ​ 784,006 ​ (142,261) ​ 641,745 Add: Notes payable, non-current portion ​ 250,000 ​ — ​ 250,000 Total notes payable as of June 30, 2024 ​ $ 1,034,006 ​ $ (142,261) ​ $ 891,745 ​ On January 22, 2024, the Company entered into a merchant cash advance agreement (the “Cash Advance Agreement”) whereby the Company received $504,900 of cash (net of underwriting fees of $35,100), and paid finder’s fees in cash of $21,600 and additional finder’s fees to be issued in equity, with the obligation to repay a total of $804,600 over thirty-two weekly payments of $25,143.75, beginning January 30, 2024. The difference between the total repayment amount and the net proceeds received was accounted for as debt discount, and along with the finder’s fees, is being amortized over thirty-two weeks using the effective interest rate method and an annualized effective interest rate of 217%. The Cash Advance Agreement was secured by the Company’s accounts receivable and related cash receipts. On February 26, 2024, the parties added an addendum to the agreement for an early payoff discount whereby the Company will owe $756,000 if paid by March 22, 2024, or $783,000 if paid by April 22, 2024. The Company did not take advantage of the early payoff discount and will continue making weekly payments over the original thirty-two-week term. On July 11, 2024, the Company used proceeds from a new merchant cash advance to repay this cash advance in full. See Note 12 – Subsequent Events – Merchant Cash Advance for additional information. On February 26, 2024, the Company entered into a merchant cash advance agreement (the “Second Cash Advance Agreement”) with the same lender mentioned above whereby the Company received $502,200 of cash (net of underwriting fees of $37,800), and paid finder’s fees in cash of $21,600 and additional finder’s fees to be issued in equity, with the obligation to repay a total of $804,600 over thirty weekly payments of $26,820, beginning February 29, 2024. The difference between the total repayment amount and the net proceeds received was accounted for as debt discount, and along with the finder’s fees, is being amortized over thirty weeks using the effective interest rate method and an annualized effective interest rate of 249%. The Second Cash Advance is secured by the Company’s accounts receivable and related cash receipts. On July 11, 2024, the terms of the agreement were revised whereby the weekly repayment amounts will be reduced from $26,820 to $15,620 and the repayment period will be extended from September 27, 2024, to November 15, 2024. On April 4, 2024, the Company and the finder of the First and Second Cash Advance Agreements determined that the equity compensation would be by issuance of warrants to purchase up to 81,788 shares (the “First Warrant”) and up to 108,389 shares (the “Second Warrant”), respectively, of the Company’s common stock at an exercise price of $0.1852 per share and $0.139 per share, respectively. The First Warrant and the Second Warrant (collectively the “Warrants”) were exercisable immediately and expire on January 22, 2027 and February 26, 2027, respectively. The Warrants had a grant date fair value of $112,863. The value of the Warrants was recognized as additional debt discount, which will be amortized over the repayment period. The Warrants contain a cashless exercise provision in the form of a net share settlement, whereby, if, at the time the holder exercises the Warrants, there is no effective registration statement registering the common stock subject to the Warrants, the holder may elect to receive the number of shares of the Company’s common stock determined according to a formula set forth in the warrant agreements. ​ The following assumptions were used in the Black-Scholes Model to measure the fair value of the warrants: ​ ​ ​ ​ ​ ​ Market price at measurement date $ 0.70 Exercise price ​ $ 0.14 - $0.19 ​ Risk free interest rate ​ 4.52 % Expected term (years) ​ 2.8 - 2.9 ​ Expected volatility ​ 93 % ​ On April 2, 2024, the Company entered into an agreement (the “Promissory Note”), with a lender (the “Lender”), pursuant to which the Lender purchased an unsecured promissory note with an initial principal amount of $500,000, for cash proceeds of $440,000. The Company recorded a debt discount of $60,000, which consists of an original issue discount of $50,000 and cash issuance costs of $10,000. The Promissory Note carries an annual interest rate of 0%, which shall increase to 15% in the event of default, and has a maturity date of October 2, 2024, after which all outstanding principal and accrued interest will become immediately due. On May 28, 2024, the Company repaid the Promissory Note in full, and recognized $60,000 of amortization expense related to the debt discount. ​ On April 9, 2024, the Company entered into a note purchase agreement pursuant to which the Company issued an unsecured promissory note with an initial principal amount of $200,000 and which matures on the first anniversary of its issuance. The Company received cash proceeds of $200,000. The promissory note carries an annual interest rate of 16%. In the event the promissory note is prepaid within 9 months of its issuance, the holder is entitled to the repayment of principal and cash payment of interest equal to 12% of the prepayment amount instead of 16%.

STOCKHOLDERS' EQUITY (DEFICIT)

STOCKHOLDERS' EQUITY (DEFICIT)	6 Months Ended
	Jun. 30, 2024
STOCKHOLDERS' EQUITY (DEFICIT)
STOCKHOLDERS' EQUITY (DEFICIT)	NOTE 10 - STOCKHOLDERS’ EQUITY (DEFICIT) Standby Equity Purchase Agreement (“SEPA”) and Supplemental SEPA On May 13, 2022, the Company entered into the SEPA with Yorkville. Pursuant to the SEPA, the Company had the right, but not the obligation, to sell to Yorkville up to an aggregate of $50,000,000 of its shares of common stock, at the Company’s request any time during the commitment period commencing on May 13, 2022, and terminating on June 1, 2024. Each sale (an “Advance”) that the Company requests under the SEPA (via an “Advance Notice”) may be for a number of shares of common stock with an aggregate value of up to $5,000,000. Shares are sold under the SEPA at 98.0% of the average of the volume-weighted average price (“VWAP”) during each of the three During the six months ended June 30, 2024, the Company issued 55,659,476 shares of common stock pursuant to SEPA Advance Notices submitted by the Company to Yorkville for aggregate gross proceeds of $15,173,357. Of the gross proceeds, $9,104,950 was retained by the Company to fund operations. The remaining proceeds were applied against the principal and interest owed in connection with the Prepaid Advance Liability. As of March 27, 2024, the Prepaid Advance Liability and the related accrued interest has been repaid in full and the SEPA terminated on June 1, 2024. See Note 6 – Prepaid Advance Liability, for details related to a supplemental agreement to the SEPA. Common Stock ​ During the six months ended June 30, 2024, the Company issued an aggregate of 79,650 shares of immediately vested common stock with a grant date value of $27,141 for legal services. During the six months ended June 30, 2024, the Company issued 454,627 shares of common stock upon the vesting of restricted stock units previously granted. During the six months ended June 30, 2024, the Company issued 30,000 shares of immediately vested common stock with a grant date value of $17,400 as equity compensation to its independent members of the Board of Directors. See Restricted Stock Awards Preferred Stock ​ On January 26, 2024, the Board of Directors (“Board”), approved, authorized, and ratified the issuance of 730,000 shares of previously designated Non-Convertible Series A Voting Preferred Stock to the Chairman and Chief Executive Officer of the Company, Michael Mo, for no consideration, subject to the Board reserving the full and unequivocal right to revoke, rescind, transfer or otherwise cancel the issued Non-convertible Series A Voting Preferred Stock in the event Michael Mo is removed from any position with the Company or resigns from all positions with the Company. The issuance of up to 1,000,000 shares of Non-Convertible Series A Voting Preferred Stock was previously approved and authorized by a vote of the majority stockholders of the Company. Holders of Non-Convertible Series A Voting Preferred Stock shall not be entitled to dividends, shall not convert into another series or class of stock of the Company and have no rights to distributions in the event of any liquidation. Each record holder of Non-Convertible Series A Voting Preferred Stock shall have that number of votes (identical in every other respect to the voting rights of the holders of Common Stock entitled to vote at any regular or special meeting of the shareholders or by written consent) equal to one-hundred (100) votes per share of Non-Convertible Series A Voting Preferred Stock held by such record holder. Treasury Stock As of June 30, 2024 and December 31, 2023, the Company has 131,162 shares held in treasury recorded at their cost of $296,222. Warrants A summary of warrants activity during the six months ended June 30, 2024, is presented below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted Weighted ​ ​ ​ ​ ​ ​ Average ​ Average ​ ​ ​ ​ ​ Number of ​ Exercise ​ Remaining ​ Intrinsic ​ Warrants Price Term (Yrs) Value Outstanding, January 1, 2024 2,524,410 ​ $ 1.02 ​ Issued 190,177 ​ 0.16 ​ Exercised — ​ — ​ Expired — ​ — ​ Forfeited — ​ — ​ Outstanding, June 30, 2024 2,714,587 ​ $ 0.96 1.6 ​ $ 45,858 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Exercisable, June 30, 2024 2,714,587 ​ $ 0.96 1.6 ​ $ 45,858 ​ A summary of outstanding and exercisable warrants as of June 30, 2024, is presented below: ​ ​ ​ ​ ​ ​ ​ ​ Warrants Outstanding ​ Warrants Exercisable ​ ​ ​ ​ Weighted ​ ​ ​ Outstanding ​ Average ​ Exercisable Exercise ​ Number of ​ Remaining Life ​ Number of Price Warrants In Years Warrants $ 1.25 ​ 177,885 ​ 1.5 ​ 177,885 $ 1.00 ​ 2,346,525 ​ 1.5 ​ 2,346,525 $ 0.19 ​ 81,788 ​ 2.6 ​ 81,788 $ 0.14 ​ 108,389 ​ 2.7 ​ 108,389 ​ ​ 2,714,587 ​ 1.6 ​ 2,714,587 ​ See Note 9 – Notes Payable for additional details related to the 2024 warrant issuances. ​ Stock Options A summary of stock options activity during the six months ended June 30, 2024, is presented below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted Weighted ​ ​ ​ ​ ​ Average ​ Average ​ ​ ​ ​ ​ Number of ​ Exercise ​ Remaining ​ Intrinsic ​ ​ Options ​ Price ​ Term (Yrs) ​ Value Outstanding, January 1, 2024 722,716 ​ $ 1.26 ​ Granted 55,000 ​ 0.27 ​ Forfeited (75,000) ​ 0.89 ​ Outstanding, June 30, 2024 702,716 ​ $ 1.22 2.5 ​ $ 7,328 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Exercisable, June 30, 2024 357,715 ​ $ 0.84 1.2 ​ $ — ​ The following table presents information related to stock options as of June 30, 2024: ​ ​ ​ ​ ​ ​ ​ ​ Options Outstanding ​ Options Exercisable ​ ​ ​ ​ Weighted ​ ​ ​ ​ Outstanding ​ Average ​ Exercisable Exercise ​ Number of ​ Remaining Term ​ Number of Price Options In Years Options $0.19 - $0.99 322,986 0.4 201,735 $1.21 - $1.50 145,000 3.5 36,250 $1.55 - $1.99 80,000 2.8 30,000 $2.05 - $2.44 154,730 2.5 89,730 ​ 702,716 1.2 357,715 ​ For the three and six months ended June 30, 2024, the weighted average grant date fair value per share of options granted was $0.21 and $0.20, respectively, compared to $0.48 and $0.74, for the three and six months ended June 30, 2023. The Company has computed the fair value of stock options granted using the Black-Scholes option pricing model. In applying the Black-Scholes option pricing model, the Company used the following range of assumptions: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Three Months Ended For The Six Months Ended ​ ​ ​ June 30, June 30, ​ ​ ​ 2024 ​ 2023 2024 ​ 2023 ​ Risk free interest rate 4.75% - 4.81 % 4.07% - 4.52 % 4.27% - 4.81 % 3.92% - 4.52 % Expected term (years) 3.8 3.5 ​ 3.8 ​ 3.5 ​ Expected volatility 110 % 107 % 110% - 114 % 105% -107 % Expected dividends 0 % 0 % 0 % 0 % ​ Option forfeitures are accounted for at the time of occurrence. The expected term used is the estimated period of time that options granted are expected to be outstanding. The Company utilizes the “simplified” method to develop an estimate of the expected term of employee option grants. The Company utilizes an expected volatility figure based on the historical volatility of its common stock over a period of time equivalent to the expected term of the instrument being valued. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued. As of June 30, 2024, there was $238,418 of unrecognized stock-based compensation expense related to the above stock options, which will be recognized over the weighted average remaining vesting period of 2.1 years. Restricted Stock Awards The following table presents information related to restricted stock awards activity during the six months ended June 30, 2024: ​ ​ ​ ​ ​ ​ ​ ​ ​ Shares of ​ Weighted Average ​ ​ Restricted ​ Grant Date ​ Common Stock Fair Value Non-vested RSAs, January 1, 2024 3,381,008 ​ $ 1.53 RSAs exchanged for RSUs ​ (2,168,508) ​ ​ 0.94 Granted — ​ — Vested (562,500) ​ 2.60 Forfeited — ​ — Non-vested RSAs, June 30, 2024 650,000 ​ $ 2.53 ​ During the six months ended June 30, 2024, the Company issued 2,168,508 restricted stock units in exchange for the same quantity of restricted stock awards. The exchange of RSAs for RSUs did not result in a modification of any other terms, such as the grant date fair value or vesting period. ​ As of June 30, 2024, there was $1,134,833 of unrecognized stock-based compensation expense related to restricted stock awards that will be recognized over the weighted average remaining vesting period of 0.91 years. ​ Restricted Stock Units The following table presents information related to restricted stock units (“RSUs”) activity during the six months ended June 30, 2024: ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of ​ Weighted Average ​ ​ Restricted ​ Grant Date ​ Common Units Fair Value Non-vested RSUs, January 1, 2024 2,250,000 ​ $ 2.05 RSAs exchanged for RSUs ​ 2,168,508 ​ ​ 0.94 Granted 851,230 ​ ​ 0.38 Vested (454,627) ​ ​ 0.94 Forfeited ​ — ​ ​ — Non-vested RSUs, June 30, 2024 ​ 4,815,111 ​ $ 1.36 ​ As of June 30, 2024, there was $4,202,362 of unrecognized stock-based compensation expense related to restricted stock units that will be recognized over the weighted average remaining vesting period of 2.68 years. Stock-Based Compensation During the three and six months ended June 30, 2024, the Company recognized stock-based compensation expense of $909,026 and $1,754,955, respectively, related to restricted stock awards, restricted stock units, stock options and stock issued for services, of which $870,837 and $1,678,942, respectively, is included within selling, general and administrative expenses, and $38,189 and $76,013, respectively is included within research and development expenses in the unaudited condensed consolidated statements of operations. During the three and six months ended June 30, 2023, the Company recognized stock-based compensation expense of $964,201 and $1,966,929, respectively, related to restricted stock awards, restricted stock units, stock options and stock issued for services, of which $927,375 and $1,831,370, respectively, is included within selling, general and administrative expenses, and $36,826 and $52,986, respectively is included within research and development expenses in the unaudited condensed consolidated statements of operations. The following table presents information related to stock-based compensation for the three and six months ended June 30, 2024 and 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Three Months Ended ​ For The Six Months Ended ​ June 30, ​ June 30, ​ 2024 2023 2024 2023 Common stock for services (includes accrued, unissued shares) ​ $ 65,523 ​ $ 96,350 ​ $ 97,915 ​ $ 210,800 Amortization of stock options ​ 29,165 ​ 44,311 ​ 61,206 ​ 84,916 Amortization of restricted stock awards and units ​ 814,338 ​ 823,540 ​ 1,595,834 ​ 1,588,640 Total ​ $ 909,026 ​ $ 964,201 ​ $ 1,754,955 ​ $ 1,884,356 ​

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2024
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 11 – COMMITMENTS AND CONTINGENCIES Legal Matters The Company may be involved in litigation and arbitrations from time to time in the ordinary course of business. As of June 30, 2024, the Company was not involved in any ongoing litigation. The Company records legal costs associated with loss contingencies as incurred. Settlements are accrued when, and if, they become probable and estimable.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2024
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 12 - SUBSEQUENT EVENTS At the Market Offering On July 3, 2024, the Company entered into an At the Market Offering agreement (the “ATM”) with an agent (the “Agent”), pursuant to which the Company may, from time to time, sell shares of common stock for aggregate gross proceeds of up to $20,000,000 in “at the market” offerings through or to the Agent. Sales of the shares of common stock, if any, will be made at prevailing market prices at the time of the sale, or as otherwise agreed with the Agent. The Agent will receive a commission from the Company of 3% of the gross proceeds of any shares of common stock sold pursuant to the ATM. During the period from July 3, 2024, through August 9, 2024, the Company issued a total of 4,953,867 shares of common stock pursuant to the ATM for aggregate proceeds of $1,416,940. Merchant Cash Advance On July 11, 2024, the Company entered into a merchant cash advance agreement (the “Third Cash Advance Agreement”) whereby the Company received $758,850 of cash (net of underwriting fees of $40,000 and $201,150 used to pay the remaining balance of the first merchant cash advance), with the obligation to repay a total of $1,350,000 over forty-three weekly payments of $31,395, beginning July 18, 2024. The agreement contains an early payoff discount whereby the Company will owe $1,230,000 if paid by August 11, 2024, or $1,310,000 if paid by September 11, 2024. The Company does not anticipate taking advantage of the early payoff discount and will continue making weekly payments over the original forty-three-week term. In addition, the Third Cash Advance Agreement amended the Second Cash Advance Agreement to revise the repayment terms, whereby the weekly repayment amounts will be reduced from $26,820 to $15,620 and the repayment period will be extended from September 27, 2024, to November 15, 2024.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (5,890,528)	$ (5,008,876)	$ (6,334,992)	$ (6,602,861)	$ (10,899,404)	$ (12,937,853)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false	false
Non-Rule 10b5-1 Arrangement Adopted	false	false
Rule 10b5-1 Arrangement Terminated	false	false
Non-Rule 10b5-1 Arrangement Terminated	false	false

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Going Concern and Management's Liquidity Plans	Going Concern and Management’s Liquidity Plans As of June 30, 2024, the Company had cash of $1,016,943 and a working capital deficit of $2,381,478. For the six months ended June 30, 2024, the Company incurred a net loss of $10,899,404 and used cash in operating activities of $9,198,453. The Company’s primary source of liquidity has historically been cash generated from equity and debt offerings along with cash flows from revenue. Under ASC Subtopic 205-40, Presentation of Financial Statements—Going Concern (“ASC 205-40”), the Company has the responsibility to evaluate whether conditions and/or events raise substantial doubt about its ability to meet future financial obligations as they become due within one year after the date that these financial statements are issued. The accompanying condensed consolidated financial statements have been prepared on the basis that we will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. However, since the Company’s inception, we have had a history of recurring net losses from operations, recurring use of cash in operating activities and working capital deficits. Future cash requirements for our current liabilities include $4,811,565 for accounts payable and accrued expenses, $784,006 for secured promissory notes (see Note 9 – Notes Payable) and $487,369 for future payments under operating leases. Future cash requirements for long-term liabilities include $1,059,898 for future payments under operating leases and $250,000 for unsecured promissory notes. On December 20, 2023, the Company received a notice of noncompliance from NYSE Regulation (“NYSE”) stating it is not in compliance with Section 1003(a)(iii) in the NYSE American Company Guide (the “Company Guide”) since the Company reported stockholders’ equity of $1,200,172 at September 30, 2023, and losses from continuing operations and/or net losses in its five most recent fiscal years. On February 12, 2024, the Company received a second notice letter from NYSE stating it is not in compliance with Section 1003 (f)(v) of the Company guide since the Company’s securities were trading at an average of less than $0.20 per share for 30 days. On March 5, 2024, the Company received a notification from the NYSE that the Company’s plan to regain compliance with Section 1003 (a)(iii) of the Company Guide was accepted and so long as the Company meets its interim objectives, the Company will have until June 20, 2025, to regain compliance with the minimum stockholders’ equity requirement. On May 1, 2024, the Company received a notification from the NYSE stating that the Company had regained compliance with Section 1003 (f)(v) of the Company Guide, given the increase in the trading price of the Company’s securities. The factors above raise substantial doubt about the Company’s ability to meet its obligations as they become due within the twelve months from the date these condensed consolidated financial statements are issued. Management’s plans to mitigate the factors which raise substantial doubt include (i) revenue growth, (ii) reducing operating expenses through careful cost management, and (iii) raising additional funds through future financings. On July 3, 2024, the Company entered into an At the Market Offering agreement (the “ATM”) with an agent (the “Agent”), pursuant to which the Company may, from time to time, sell shares of common stock having an aggregate offering price of up to $20,000,000 in “at the market” offerings through or to the Agent. Sales of the shares of common stock, if any, will be made at prevailing market prices at the time of the sale, or as otherwise agreed with the Agent. The Agent will receive a commission from the Company of 3% of the gross proceeds of any shares of common stock sold under the Sales Agreement. During the period from July 3, 2024, through August 9, 2024, the Company issued a total of 4,953,867 shares of common stock pursuant to the Sales Agreement for aggregate proceeds of $1,416,940. See Note 12 – Subsequent Events – At the Market Offering for additional information. The Company’s ability to continue as a going concern is dependent upon its ability to successfully execute the aforementioned initiatives. There is no assurance that the amount of funds the Company might raise will enable the Company to complete its development initiatives or attain profitable operations. The aforementioned factors indicate that management’s plans do not alleviate the substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements. These unaudited condensed consolidated financial statements do not include any adjustments relating to the recoverability of assets and the amounts and classification of liabilities that may be necessary should the Company be unable to continue as a going concern.
Use of Estimates	Use of Estimates Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the financial statements. The Company’s significant estimates used in these unaudited condensed consolidated financial statements include, but are not limited to, fair value calculations for intangible assets, equity securities, stock-based compensation and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consisted primarily of cash and accounts receivable. The Company’s concentrations of credit risk also include concentrations from key customers and vendors. Cash Concentrations A significant portion of the Company’s cash is held at one major financial institution. The Company has not experienced any losses in such accounts. Cash held in US bank institutions is currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 at each institution. There were uninsured balances of $516,943 and $694,764 as of June 30, 2024 and December 31, 2023, respectively. Customer and Revenue Concentrations The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, or whose accounts receivable balances individually represented 10% or more of the Company’s total accounts receivable, as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Revenue ​ Accounts Receivable ​ ​ For the Three Months Ended ​ For the Six Months Ended ​ As of ​ As of ​ ​ June 30, ​ June 30, ​ June 30, December 31, ​ 2024 2023 2024 2023 2024 ​ 2023 Customer A 31 % * ​ 18 % * ​ 43 % * ​ Customer B 19 % * ​ 11 % * ​ 24 % * ​ Customer C 10 % * ​ * ​ * ​ * ​ 52 % Customer D ​ * ​ 46 % * ​ 63 % * ​ 20 % Customer E ​ * ​ 19 % * ​ * ​ * ​ 14 % Customer F ​ * ​ 17 % * ​ 10 % * ​ * ​ Customer G ​ * ​ * ​ 17 % * ​ * ​ * ​ Total 60 % 82 % 46 % 73 % 67 % 86 % * Less than 10% ​ There is no assurance the Company will continue to receive significant revenue from any of these customers. Any reduction or delay in operating activity from any of the Company’s significant customers, or a delay or default in payment by any significant customer, or termination of agreements with significant customers, could materially harm the Company’s business and prospects. As a result of the Company’s significant customer concentrations, its gross profit and results from operations could fluctuate significantly due to changes in political, environmental, or economic conditions, or the loss of, reduction of business from, or less favorable terms with any of the Company’s significant customers. Vendor Concentrations The Company had vendors whose purchases of inventory individually represented 10% or more of the Company’s total purchases of inventory, for the three and six months ended June 30, 2024 and 2023, as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended For the Six Months Ended ​ ​ June 30, June 30, ​ ​ 2024 2023 2024 2023 ​ Vendor A 19 % * ​ 29 % * ​ Vendor B 19 % * ​ 28 % * ​ Vendor C ​ * ​ 16 % * ​ 14 % Vendor D * ​ 10 % * ​ * ​ ​ 38 % 26 % 57 % 14 % * Less than 10% Accounts Receivable Accounts receivable are carried at their contractual amounts, less an estimate for credit losses. As of June 30, 2024 and December 31, 2023, no allowances for credit losses were determined to be necessary. Management estimates the allowance for credit losses based on existing economic conditions, the financial conditions of the customers, and the amount and age of past due accounts. Receivables are considered past due if full payment is not received by the contractual due date. Past due accounts are generally written off against the allowance for credit losses only after all collection attempts have been exhausted.
Inventory	Inventory The Company capitalizes inventory costs associated with products when future commercialization is considered probable, and a future economic benefit is expected to be realized. These costs consist of finished goods, raw materials, manufacturing-related costs, transportation and freight, and other indirect overhead costs. Inventory is comprised of carbon fiber velvet (“CFV”) thermal interface solutions and internal short circuit batteries, which are available for sale, as well as raw materials and work in process related primarily to the manufacture of safe cases. Safe cases provide a safe and cost-effective solution to commercially store and transport lithium batteries and mitigate the impacts of cell-to-cell thermal runway propagation. Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out method. The cost of inventory that is sold to third parties is included within cost of revenue and the cost of inventory that is given as samples is included within operating expenses. The Company periodically reviews for slow-moving, excess or obsolete inventories. Products that are determined to be obsolete, if any, are written down to net realizable value. On occasion, the Company pays for inventory prior to receiving the goods. These payments are recorded as inventory deposits until the goods are received and these costs are included in the current asset section of the condensed consolidated balance sheets. As of June 30, 2024 and December 31, 2023, inventory deposits were $10,883 and $27,500 , respectively. Finished goods inventory is held on-site at the San Diego, California and Webster, Texas locations. Certain raw materials are held off-site with certain contract manufacturers. Inventory at June 30, 2024 and December 31, 2023 was comprised of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, December 31, ​ ​ 2024 ​ 2023 Raw materials ​ $ 409,168 ​ $ 322,111 Finished goods ​ 126,028 ​ 826,936 Total inventory ​ $ 535,196 ​ $ 1,149,047 ​
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The following five steps are applied to achieve that core principle: ● Step 1: Identify the contract with the customer; ● Step 2: Identify the performance obligations in the contract; ● Step 3: Determine the transaction price; ● Step 4: Allocate the transaction price to the performance obligations in the contract; and ● Step 5: Recognize revenue when the company satisfies a performance obligation. The Company recognizes revenue primarily from the following different types of contracts: ● Product sales – Revenue is recognized at the point in time the customer obtains control of the goods and the Company satisfies its performance obligation, which is generally at the time it ships the product to the customer. ● Contract services – Revenue is recognized pursuant to the terms of each individual contract when the Company satisfies the respective performance obligations, which could be recognized at a point in time or over the term of the contract. Contract services revenue that is recognized over time, may be recognized using the input method, based on labor hours expended, or using the output method based on milestones achieved, depending on the contract. The following table summarizes the Company’s revenue recognized by type of contract in its condensed consolidated statements of operations: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Six Months Ended ​ ​ June 30, ​ June 30, ​ 2024 2023 2024 2023 Revenue Recognized at a Point in Time: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Product sales ​ $ 1,134,769 ​ $ 1,957,370 ​ $ 1,749,862 ​ $ 3,586,628 Contract services ​ ​ 1,185,236 ​ ​ 270,476 ​ ​ 1,701,707 ​ ​ 401,020 Total ​ ​ 2,320,005 ​ ​ 2,227,846 ​ ​ 3,451,569 ​ ​ 3,987,648 Revenue Recognized Over Time: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Contract services ​ 112,000 ​ 467,660 ​ 729,540 ​ 467,660 Total Revenue ​ $ 2,432,005 ​ $ 2,695,506 ​ $ 4,181,109 ​ $ 4,455,308 ​
Net Loss Per Common Share	Net Loss Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common and dilutive common-equivalent shares outstanding during each period. ​ The following table presents the computation of basic and diluted net loss per common share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended For the Six Months Ended ​ ​ June 30, ​ June 30, ​ ​ 2024 2023 ​ 2024 2023 Numerator: ​ ​ ​ ​ Net loss ​ $ (5,890,528) ​ $ (6,334,992) ​ $ (10,899,404) ​ $ (12,937,853) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator (weighted average quantities): ​ ​ ​ ​ ​ ​ ​ ​ Common shares issued ​ 182,151,812 ​ 118,617,860 ​ 162,824,020 ​ 116,846,331 Less: Treasury shares purchased ​ (131,162) ​ (131,162) ​ (131,162) ​ (131,162) Less: Unvested restricted shares ​ (690,248) ​ (3,240,679) ​ (880,871) ​ ​ (2,708,655) Add: Accrued issuable equity ​ ​ 136,862 ​ ​ 134,681 ​ ​ 102,647 ​ ​ 127,359 Denominator for basic and diluted net loss per share ​ ​ 181,467,264 ​ ​ 115,380,700 ​ ​ 161,914,634 ​ ​ 114,133,873 ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net loss per common share ​ $ (0.03) ​ $ (0.05) ​ $ (0.07) ​ $ (0.11) ​ The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive: ​ ​ ​ ​ ​ ​ ​ ​ June 30, ​ 2024 2023 Prepaid advance liability (1) ​ — ​ 10,168,469 Unvested restricted stock awards ​ 650,000 ​ 3,116,008 Unvested restricted stock units ​ 4,825,111 ​ 3,000,000 Options 702,716 795,216 Warrants ​ 2,714,587 ​ 2,524,410 Total 8,892,414 19,604,103 (1)
Operating Leases	Operating Leases The Company leases properties under operating leases. For leases in effect upon adoption of Accounting Standards Update (“ASU”) 2016-02, “Leases (Topic 842)” at January 1, 2020, and for any leases commencing thereafter, the Company recognizes a liability to make lease payments, the “lease liability”, and an asset representing the right to use the underlying asset during the lease term, the “right-of-use asset”. The lease liability is measured at the present value of the remaining lease payments, discounted at the Company’s incremental borrowing rate. The right-of-use asset is measured at the amount of the lease liability adjusted for any lease incentives received, any cumulative prepaid or accrued rent if the lease payments are uneven throughout the lease term, any unamortized initial direct costs, and any impairment of the right-of-use-asset. Operating lease expense consists of a single lease cost calculated so that the remaining cost of the lease is allocated over the remaining lease term on a straight-line basis, variable lease payments not included in the lease liability, and any impairment of the right-of-use asset. The Company elected the accounting policy to include both the lease and non-lease components of the agreements as a single component and account for them as a lease.
Reclassifications	Reclassifications Certain prior period balances have been reclassified to conform to the current period presentation. These reclassifications have no effect on previously reported results of operations or loss per share.
Subsequent Events	Subsequent Events The Company has evaluated subsequent events through the date on which these unaudited condensed consolidated financial statements were issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, except as disclosed in Note 12 – Subsequent Events.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (the “FASB”) FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” These amendments require a public entity to disclose significant segment expenses and other segment items on an annual and interim basis and to provide in interim periods all disclosures about a reportable segment’s profit or loss and assets that are currently required annually. Public entities with a single reporting segment are required to provide both the new disclosures and all of the existing disclosures required under ASC 280. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating any new disclosures that may be required upon adoption of ASU 2023-07. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The amendments in ASU 2023 – 09 are effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating any new disclosures that may be required upon adoption of ASU 2023–09. Recently Adopted Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity; Own Equity (“ASU 2020-06”), as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. Among other changes, the new guidance removes from GAAP separation models for convertible debt that require the convertible debt to be separated into a debt and equity component, unless the conversion feature is required to be bifurcated and accounted for as a derivative or the debt is issued at a substantial premium. As a result, after adopting the guidance, entities will no longer separately present such embedded conversion features in equity and will instead account for the convertible debt wholly as debt. The new guidance also requires use of the “if-converted” method when calculating the dilutive impact of convertible debt on earnings per share, which is consistent with the Company’s current accounting treatment under the current guidance. The guidance is effective for the Company in financial statements issued for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted, but only at the beginning of the fiscal year. The Company adopted this ASU on January 1, 2024, and the adoption did not have a material impact on its condensed consolidated financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of concentrations of credit risk	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Revenue ​ Accounts Receivable ​ ​ For the Three Months Ended ​ For the Six Months Ended ​ As of ​ As of ​ ​ June 30, ​ June 30, ​ June 30, December 31, ​ 2024 2023 2024 2023 2024 ​ 2023 Customer A 31 % * ​ 18 % * ​ 43 % * ​ Customer B 19 % * ​ 11 % * ​ 24 % * ​ Customer C 10 % * ​ * ​ * ​ * ​ 52 % Customer D ​ * ​ 46 % * ​ 63 % * ​ 20 % Customer E ​ * ​ 19 % * ​ * ​ * ​ 14 % Customer F ​ * ​ 17 % * ​ 10 % * ​ * ​ Customer G ​ * ​ * ​ 17 % * ​ * ​ * ​ Total 60 % 82 % 46 % 73 % 67 % 86 % * Less than 10% ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended For the Six Months Ended ​ ​ June 30, June 30, ​ ​ 2024 2023 2024 2023 ​ Vendor A 19 % * ​ 29 % * ​ Vendor B 19 % * ​ 28 % * ​ Vendor C ​ * ​ 16 % * ​ 14 % Vendor D * ​ 10 % * ​ * ​ ​ 38 % 26 % 57 % 14 % * Less than 10%
Schedule of inventory	​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, December 31, ​ ​ 2024 ​ 2023 Raw materials ​ $ 409,168 ​ $ 322,111 Finished goods ​ 126,028 ​ 826,936 Total inventory ​ $ 535,196 ​ $ 1,149,047
Schedule of revenue recognized	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Six Months Ended ​ ​ June 30, ​ June 30, ​ 2024 2023 2024 2023 Revenue Recognized at a Point in Time: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Product sales ​ $ 1,134,769 ​ $ 1,957,370 ​ $ 1,749,862 ​ $ 3,586,628 Contract services ​ ​ 1,185,236 ​ ​ 270,476 ​ ​ 1,701,707 ​ ​ 401,020 Total ​ ​ 2,320,005 ​ ​ 2,227,846 ​ ​ 3,451,569 ​ ​ 3,987,648 Revenue Recognized Over Time: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Contract services ​ 112,000 ​ 467,660 ​ 729,540 ​ 467,660 Total Revenue ​ $ 2,432,005 ​ $ 2,695,506 ​ $ 4,181,109 ​ $ 4,455,308
Schedule of of basic and diluted net loss per common share	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended For the Six Months Ended ​ ​ June 30, ​ June 30, ​ ​ 2024 2023 ​ 2024 2023 Numerator: ​ ​ ​ ​ Net loss ​ $ (5,890,528) ​ $ (6,334,992) ​ $ (10,899,404) ​ $ (12,937,853) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator (weighted average quantities): ​ ​ ​ ​ ​ ​ ​ ​ Common shares issued ​ 182,151,812 ​ 118,617,860 ​ 162,824,020 ​ 116,846,331 Less: Treasury shares purchased ​ (131,162) ​ (131,162) ​ (131,162) ​ (131,162) Less: Unvested restricted shares ​ (690,248) ​ (3,240,679) ​ (880,871) ​ ​ (2,708,655) Add: Accrued issuable equity ​ ​ 136,862 ​ ​ 134,681 ​ ​ 102,647 ​ ​ 127,359 Denominator for basic and diluted net loss per share ​ ​ 181,467,264 ​ ​ 115,380,700 ​ ​ 161,914,634 ​ ​ 114,133,873 ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net loss per common share ​ $ (0.03) ​ $ (0.05) ​ $ (0.07) ​ $ (0.11) ​
Schedule of shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive	​ ​ ​ ​ ​ ​ ​ ​ June 30, ​ 2024 2023 Prepaid advance liability (1) ​ — ​ 10,168,469 Unvested restricted stock awards ​ 650,000 ​ 3,116,008 Unvested restricted stock units ​ 4,825,111 ​ 3,000,000 Options 702,716 795,216 Warrants ​ 2,714,587 ​ 2,524,410 Total 8,892,414 19,604,103 (1)

PREPAID EXPENSES AND OTHER CU_2

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)	6 Months Ended
	Jun. 30, 2024
PREPAID EXPENSES AND OTHER CURRENT ASSETS
Schedule of prepaid expenses and other current assets	​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, December 31, ​ 2024 2023 Compensation costs ​ $ 225,000 ​ $ 375,000 Dues and subscriptions ​ ​ 55,189 ​ ​ 50,689 Deferred expenses ​ ​ 53,247 ​ ​ 59,089 Professional fees ​ ​ 13,506 ​ ​ 24,125 Vendor receivables ​ ​ 7,389 ​ ​ 1,995 Security deposits ​ ​ 5,095 ​ ​ 55,308 Insurance ​ ​ 116 ​ ​ 32,606 Conferences and seminars ​ ​ — ​ ​ 19,338 Investor relations ​ ​ — ​ ​ 1,512 Other ​ ​ 16,214 ​ ​ 11,699 Total prepaid expenses and other current assets ​ $ 375,756 ​ $ 631,361 ​

ACCRUED EXPENSES AND OTHER CU_2

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)	6 Months Ended
	Jun. 30, 2024
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Schedule of accrued expenses and other current liabilities	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, ​ December 31, ​ 2024 2023 Professional fees ​ $ 2,094,938 ​ $ 1,875,000 Research and development ​ ​ 441,192 ​ ​ 441,192 Payroll and vacation ​ ​ 412,974 ​ ​ 504,748 Inventory purchases ​ 291,925 ​ ​ 145,949 Sales tax payable ​ ​ 110,473 ​ ​ 46,901 Legal fees ​ 110,000 ​ ​ 117,640 Royalties ​ ​ 58,841 ​ ​ 17,505 Board compensation ​ 37,500 ​ ​ 23,750 Securities fees ​ 37,500 ​ ​ — Refund due to customer ​ — ​ ​ 171,960 Cost of sales ​ ​ — ​ ​ 28,663 Other ​ ​ 155,528 ​ ​ 90,036 Total accrued expenses and other current liabilities ​ 3,750,871 ​ ​ 3,463,344 Add: Accrued interest, non-current ​ ​ — ​ ​ 5,899 Total accrued expenses and other liabilities ​ $ 3,750,871 ​ $ 3,469,243 ​

ACCRUED ISSUABLE EQUITY (Tables

ACCRUED ISSUABLE EQUITY (Tables)	6 Months Ended
	Jun. 30, 2024
ACCRUED ISSUABLE EQUITY
Summary of accrued issuable equity	​ ​ ​ ​ ​ ​ ​ For the Six Months Ended ​ June 30, 2024 Beginning balance at January 1, 2024 ​ $ 13,002 Additions ​ ​ 53,375 Mark-to-market ​ ​ 15,739 Fair value at June 30, 2024 ​ $ 82,116

PREPAID ADVANCE LIABILITY, NE_2

PREPAID ADVANCE LIABILITY, NET OF DISCOUNT (Tables)	6 Months Ended
	Jun. 30, 2024
PREPAID ADVANCE LIABILITY, NET OF DISCOUNT
Schedule of prepaid advance liability, net of discount	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross Amount of Less: Prepaid Advance ​ ​ Prepaid Advance ​ Debt ​ Liability, ​ ​ Liability ​ Discount ​ net of discount Balance, January 1, 2024 ​ $ 5,918,430 ​ $ (26,374) ​ $ 5,892,056 Repayments pursuant to Advance Notices ​ (5,918,430) ​ — ​ (5,918,430) Amortization of debt discount ​ — ​ 26,374 ​ 26,374 Balance, June 30, 2024 ​ $ — ​ $ — ​ $ —

LEASES (Tables)

LEASES (Tables)	6 Months Ended
	Jun. 30, 2024
LEASES
Schedule of maturities of lease liabilities	Maturities of lease liabilities as of June 30, 2024, were as follows: ​ ​ ​ ​ ​ Year ​ July 1, 2024 through December 31, 2024 ​ $ 307,722 2025 ​ ​ 601,196 2026 ​ ​ 280,228 2027 ​ 289,008 2028 ​ ​ 297,788 Thereafter ​ ​ 101,703 Total future minimum lease payments ​ 1,877,645 Less: amount representing imputed interest ​ ​ (330,378) Present value of lease liabilities ​ ​ 1,547,267 Less: current portion ​ ​ (487,369) Lease liabilities, non current portion ​ $ 1,059,898
Schedule of supplemental cash flow information related to the leases	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Six Months Ended ​ June 30, ​ ​ ​ 2024 2023 ​ Cash paid for amounts included in the measurement of lease liabilities: ​ ​ ​ ​ ​ ​ ​ Operating cash flows used in operating activities ​ $ 130,838 ​ $ 130,678 ​ Right-of-use assets obtained in exchange for lease obligations ​ ​ ​ ​ ​ ​ ​ Operating leases ​ $ 1,575,919 ​ $ 51,154 ​ Weighted Average Remaining Lease Term (Years) ​ ​ ​ ​ ​ ​ ​ Operating leases ​ ​ 3.77 years ​ 0.88 years Weighted Average Discount Rate ​ ​ ​ ​ ​ ​ ​ Operating leases ​ ​ 10.0 % ​ 5.0 % ​

NOTES PAYABLE (Tables)

NOTES PAYABLE (Tables)	6 Months Ended
	Jun. 30, 2024
NOTES PAYABLE
Summary of notes payable activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Notes Debt ​ ​ ​ ​ Payable ​ Discount ​ Total Outstanding, January 1, 2024 ​ $ — ​ $ — ​ — Proceeds from merchant cash advances ​ 1,609,200 ​ (529,200) ​ 1,080,000 Proceeds from promissory notes ​ ​ 700,000 ​ ​ (50,000) ​ ​ 650,000 Issuance costs paid in cash ​ — ​ (53,200) ​ (53,200) Issuance costs to be paid in equity ​ — ​ ​ (112,863) ​ (112,863) Underwriting fees paid in cash ​ — ​ ​ (72,900) ​ (72,900) Repayments in cash ​ (1,525,195) ​ — ​ (1,525,195) Amortization of debt discount ​ — ​ 675,902 ​ 675,902 Notes payable, current-portion ​ 784,006 ​ (142,261) ​ 641,745 Add: Notes payable, non-current portion ​ 250,000 ​ — ​ 250,000 Total notes payable as of June 30, 2024 ​ $ 1,034,006 ​ $ (142,261) ​ $ 891,745
Schedule of range of assumptions used in the fair valuation of stock options	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Three Months Ended For The Six Months Ended ​ ​ ​ June 30, June 30, ​ ​ ​ 2024 ​ 2023 2024 ​ 2023 ​ Risk free interest rate 4.75% - 4.81 % 4.07% - 4.52 % 4.27% - 4.81 % 3.92% - 4.52 % Expected term (years) 3.8 3.5 ​ 3.8 ​ 3.5 ​ Expected volatility 110 % 107 % 110% - 114 % 105% -107 % Expected dividends 0 % 0 % 0 % 0 %
Warrants
NOTES PAYABLE
Schedule of range of assumptions used in the fair valuation of stock options	​ ​ ​ ​ ​ ​ Market price at measurement date $ 0.70 Exercise price ​ $ 0.14 - $0.19 ​ Risk free interest rate ​ 4.52 % Expected term (years) ​ 2.8 - 2.9 ​ Expected volatility ​ 93 %

STOCKHOLDERS' EQUITY (DEFICIT)

STOCKHOLDERS' EQUITY (DEFICIT) (Tables)	6 Months Ended
	Jun. 30, 2024
STOCKHOLDERS' EQUITY (DEFICIT)
Summary of warrants activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted Weighted ​ ​ ​ ​ ​ ​ Average ​ Average ​ ​ ​ ​ ​ Number of ​ Exercise ​ Remaining ​ Intrinsic ​ Warrants Price Term (Yrs) Value Outstanding, January 1, 2024 2,524,410 ​ $ 1.02 ​ Issued 190,177 ​ 0.16 ​ Exercised — ​ — ​ Expired — ​ — ​ Forfeited — ​ — ​ Outstanding, June 30, 2024 2,714,587 ​ $ 0.96 1.6 ​ $ 45,858 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Exercisable, June 30, 2024 2,714,587 ​ $ 0.96 1.6 ​ $ 45,858
Summary of outstanding and exercisable warrants	​ ​ ​ ​ ​ ​ ​ ​ Warrants Outstanding ​ Warrants Exercisable ​ ​ ​ ​ Weighted ​ ​ ​ Outstanding ​ Average ​ Exercisable Exercise ​ Number of ​ Remaining Life ​ Number of Price Warrants In Years Warrants $ 1.25 ​ 177,885 ​ 1.5 ​ 177,885 $ 1.00 ​ 2,346,525 ​ 1.5 ​ 2,346,525 $ 0.19 ​ 81,788 ​ 2.6 ​ 81,788 $ 0.14 ​ 108,389 ​ 2.7 ​ 108,389 ​ ​ 2,714,587 ​ 1.6 ​ 2,714,587
Summary of stock options activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted Weighted ​ ​ ​ ​ ​ Average ​ Average ​ ​ ​ ​ ​ Number of ​ Exercise ​ Remaining ​ Intrinsic ​ ​ Options ​ Price ​ Term (Yrs) ​ Value Outstanding, January 1, 2024 722,716 ​ $ 1.26 ​ Granted 55,000 ​ 0.27 ​ Forfeited (75,000) ​ 0.89 ​ Outstanding, June 30, 2024 702,716 ​ $ 1.22 2.5 ​ $ 7,328 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Exercisable, June 30, 2024 357,715 ​ $ 0.84 1.2 ​ $ —
Schedule of information related to stock options exercise price	​ ​ ​ ​ ​ ​ ​ ​ Options Outstanding ​ Options Exercisable ​ ​ ​ ​ Weighted ​ ​ ​ ​ Outstanding ​ Average ​ Exercisable Exercise ​ Number of ​ Remaining Term ​ Number of Price Options In Years Options $0.19 - $0.99 322,986 0.4 201,735 $1.21 - $1.50 145,000 3.5 36,250 $1.55 - $1.99 80,000 2.8 30,000 $2.05 - $2.44 154,730 2.5 89,730 ​ 702,716 1.2 357,715
Schedule of range of assumptions used in the fair valuation of stock options	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Three Months Ended For The Six Months Ended ​ ​ ​ June 30, June 30, ​ ​ ​ 2024 ​ 2023 2024 ​ 2023 ​ Risk free interest rate 4.75% - 4.81 % 4.07% - 4.52 % 4.27% - 4.81 % 3.92% - 4.52 % Expected term (years) 3.8 3.5 ​ 3.8 ​ 3.5 ​ Expected volatility 110 % 107 % 110% - 114 % 105% -107 % Expected dividends 0 % 0 % 0 % 0 %
Schedule of restricted stock awards (RSAs) activity	​ ​ ​ ​ ​ ​ ​ ​ ​ Shares of ​ Weighted Average ​ ​ Restricted ​ Grant Date ​ Common Stock Fair Value Non-vested RSAs, January 1, 2024 3,381,008 ​ $ 1.53 RSAs exchanged for RSUs ​ (2,168,508) ​ ​ 0.94 Granted — ​ — Vested (562,500) ​ 2.60 Forfeited — ​ — Non-vested RSAs, June 30, 2024 650,000 ​ $ 2.53
Schedule of restricted stock units (RSUs) activity	​ ​ ​ ​ ​ ​ ​ ​ ​ Number of ​ Weighted Average ​ ​ Restricted ​ Grant Date ​ Common Units Fair Value Non-vested RSUs, January 1, 2024 2,250,000 ​ $ 2.05 RSAs exchanged for RSUs ​ 2,168,508 ​ ​ 0.94 Granted 851,230 ​ ​ 0.38 Vested (454,627) ​ ​ 0.94 Forfeited ​ — ​ ​ — Non-vested RSUs, June 30, 2024 ​ 4,815,111 ​ $ 1.36
Schedule of information relating to stock -based compensation	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Three Months Ended ​ For The Six Months Ended ​ June 30, ​ June 30, ​ 2024 2023 2024 2023 Common stock for services (includes accrued, unissued shares) ​ $ 65,523 ​ $ 96,350 ​ $ 97,915 ​ $ 210,800 Amortization of stock options ​ 29,165 ​ 44,311 ​ 61,206 ​ 84,916 Amortization of restricted stock awards and units ​ 814,338 ​ 823,540 ​ 1,595,834 ​ 1,588,640 Total ​ $ 909,026 ​ $ 964,201 ​ $ 1,754,955 ​ $ 1,884,356 ​

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Customer, Revenue and Vendor Concentrations (Details)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Revenue | Total Customers | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage	60%	82%	46%	73%
Revenue | Customer A | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage	31%		18%
Revenue | Customer B | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage	19%		11%
Revenue | Customer C | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage	10%
Revenue | Customer D | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage		46%		63%
Revenue | Customer E | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage		19%
Revenue | Customer G | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage			17%
Revenue | Customer F | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage		17%		10%
Account Receivables | Total Customers | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage			67%		86%
Account Receivables | Customer A | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage			43%
Account Receivables | Customer B | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage			24%
Account Receivables | Customer C | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage					52%
Account Receivables | Customer D | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage					20%
Account Receivables | Customer E | Revenue Concentrations
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage					14%
Accounts Payable | Vendor Concentrations | Total Vendors
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage	38%	26%	57%	14%
Accounts Payable | Vendor Concentrations | Vendor A
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage	19%		29%
Accounts Payable | Vendor Concentrations | Vendor B
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage	19%		28%
Accounts Payable | Vendor Concentrations | Vendor C
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage		16%		14%
Accounts Payable | Vendor Concentrations | Vendor D
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Concentration risk percentage		10%

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventory (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Raw materials	$ 409,168	$ 322,111
Finished goods	126,028	826,936
Total inventory	$ 535,196	$ 1,149,047

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Company's revenue recognized in its consolidated statements of operations (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Total revenue	$ 2,432,005	$ 2,695,506	$ 4,181,109	$ 4,455,308
Revenues Recognized at a Point in Time
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Total revenue	2,320,005	2,227,846	3,451,569	3,987,648
Revenues Recognized at a Point in Time | Product sales
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Total revenue	1,134,769	1,957,370	1,749,862	3,586,628
Revenues Recognized at a Point in Time | Contract services
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Total revenue	1,185,236	270,476	1,701,707	401,020
Revenues Recognized Over Time
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Total revenue	2,432,005	2,695,506	4,181,109	4,455,308
Revenues Recognized Over Time | Contract services
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Total revenue	$ 112,000	$ 467,660	$ 729,540	$ 467,660

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of basic and diluted net loss per common share (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Numerator:
Net Income (Loss)	$ (5,890,528)	$ (5,008,876)	$ (6,334,992)	$ (6,602,861)	$ (10,899,404)	$ (12,937,853)
Denominator (weighted average quantities):
Common shares issued	182,151,812		118,617,860		162,824,020	116,846,331
Less: Treasury shares purchased	(131,162)		(131,162)		(131,162)	(131,162)
Less: Unvested restricted shares	(690,248)		(3,240,679)		(880,871)	(2,708,655)
Add: Accrued issuable equity	136,862		134,681		102,647	127,359
Denominator for basic net loss per share	181,467,264		115,380,700		161,914,634	114,133,873
Denominator for diluted net loss per share	181,467,264		115,380,700		161,914,634	114,133,873
Basic net loss per common share (In dollars per share)	$ (0.03)		$ (0.05)		$ (0.07)	$ (0.11)
Diluted net loss per common share (In dollars per share)	$ (0.03)		$ (0.05)		$ (0.07)	$ (0.11)

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive (Details) - $ / shares	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares were excluded from the calculation of weighted average dilutive common shares	8,892,414	19,604,103
Floor price	$ 0.75
Prepaid advance liability
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares were excluded from the calculation of weighted average dilutive common shares		10,168,469
Unvested restricted stock awards
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares were excluded from the calculation of weighted average dilutive common shares	650,000	3,116,008
Unvested restricted stock units
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares were excluded from the calculation of weighted average dilutive common shares	4,825,111	3,000,000
Employee Stock Option
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares were excluded from the calculation of weighted average dilutive common shares	702,716	795,216
Warrants
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares were excluded from the calculation of weighted average dilutive common shares	2,714,587	2,524,410

SUMMARY OF SIGNIFICANT ACCOUN_9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($)		1 Months Ended	3 Months Ended				6 Months Ended
	Jul. 03, 2024	Aug. 09, 2024	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Feb. 12, 2024	Dec. 31, 2023	Nov. 07, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash			$ 1,016,943				$ 1,016,943			$ 1,194,764
Working capital deficit			(2,381,478)				(2,381,478)
Net Income (Loss)			(5,890,528)	$ (5,008,876)	$ (6,334,992)	$ (6,602,861)	(10,899,404)	$ (12,937,853)
Cash in operations							9,198,453	9,858,687
Current liabilities include accounts payable and accrued expenses			4,811,565				4,811,565
Merchant cash advances			784,006				784,006
Lease liabilities, current portion			487,369				487,369			102,186
Lease liabilities, non-current portion			1,059,898				1,059,898
Stockholders' equity			3,835,093	2,589,598	$ 3,473,633	$ 8,225,116	3,835,093	$ 3,473,633		(2,182,696)		$ 10,493,733
Average trading price per share									$ 0.20
Proceeds from common stock issued for cash pursuant to Advance Notices			6,194,299	2,910,651
Underwritten limited public offering issuance costs			52,792	$ 4,238
Uninsured cash			516,943				516,943			694,764
Inventory deposits			10,883				10,883			$ 27,500
Yorkville
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Stockholders' equity			$ 1,200,172				1,200,172
Proceeds from common stock issued for cash pursuant to Advance Notices							15,173,357
Yorkville | Payable on or before November 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Lease liabilities, current portion											$ 487,369
Yorkville | Payable on or before January 31, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Lease liabilities, non-current portion											1,059,898
Promissory notes payable, non current											$ 250,000
ATM
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Percentage of Commission to Agent in Proportion to Gross Proceeds	3%
ATM | Subsequent event
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Maximum aggregate offering price	$ 20,000,000
Common stock issued (in shares)		4,953,867
Proceeds from common stock issued for cash pursuant to Advance Notices		$ 1,416,940
SEPA | Yorkville
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Proceeds from common stock issued for cash pursuant to Advance Notices							$ 15,173,357

PREPAID EXPENSES AND OTHER CU_3

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
PREPAID EXPENSES AND OTHER CURRENT ASSETS
Compensation costs	$ 225,000	$ 375,000
Dues and subscriptions	55,189	50,689
Deferred expenses	53,247	59,089
Professional fees	13,506	24,125
Vendor receivables	7,389	1,995
Security deposits	5,095	55,308
Insurance	116	32,606
Conferences and seminars		19,338
Investor relations		1,512
Other	16,214	11,699
Total prepaid expenses and other current assets	$ 375,756	$ 631,361

ACCRUED EXPENSES AND OTHER CU_3

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Professional fees	$ 2,094,938	$ 1,875,000
Research and development	441,192	441,192
Payroll and vacation	412,974	504,748
Inventory purchases	291,925	145,949
Sales tax payable	110,473	46,901
Legal fees	110,000	117,640
Royalties	58,841	17,505
Board compensation	37,500	23,750
Securities fees	37,500
Refund due to customer		171,960
Cost of sales		28,663
Other	155,528	90,036
Total accrued expenses and other current liabilities	3,750,871	3,463,344
Add: Accrued interest, non-current		5,899
Total accrued expenses and other liabilities	$ 3,750,871	$ 3,469,243

ACCRUED ISSUABLE EQUITY (Detail

ACCRUED ISSUABLE EQUITY (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
ACCRUED ISSUABLE EQUITY
Beginning balance at January 1, 2024			$ 13,002
Additions			53,375
Mark-to market	$ (2,737)	$ 156,652	15,739	$ 220,760
Fair value at March 31, 2024	$ 82,116		$ 82,116

ACCRUED ISSUABLE EQUITY - Addit

ACCRUED ISSUABLE EQUITY - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
ACCRUED ISSUABLE EQUITY
Estimated fair value of shares			$ 53,375
Aggregate amount of mark-to market related to changes in fair value of accrued issuable equity	$ (2,737)	$ 156,652	15,739	$ 220,760
Fair value of unissued share	$ 82,116		$ 82,116

PREPAID ADVANCE LIABILITY, NE_3

PREPAID ADVANCE LIABILITY, NET OF DISCOUNT - Prepaid advance liability (Details)	6 Months Ended
	Jun. 30, 2024 USD ($)
PREPAID ADVANCE LIABILITY, NET OF DISCOUNT
Gross Amount of Prepaid Advance Liability	$ 5,918,430
Debt Discount	(26,374)
Prepaid Advance Liability, net of discount	5,892,056
Repayments pursuant to Advance Notices	(5,918,430)
Notes Payable
PREPAID ADVANCE LIABILITY, NET OF DISCOUNT
Amortization of debt discount	$ 26,374

PREPAID ADVANCE LIABILITY, NE_4

PREPAID ADVANCE LIABILITY, NET OF DISCOUNT - Additional Information (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jan. 09, 2024
PREPAID ADVANCE LIABILITY, NET OF DISCOUNT
Proceeds from common stock issued for cash pursuant to Advance Notices	$ 6,194,299	$ 2,910,651
Common stock issued for the repayment of prepaid advance liability and related interest accrual			$ 715,658	$ 3,750,968
Loss on debt extinguishment					$ (31,358)
Yorkville
PREPAID ADVANCE LIABILITY, NET OF DISCOUNT
Prepaid advance						$ 2,000,000
Percentage of cash payment premium payable on or before December 31, 2023						5%
Number of shares issued (in shares)					55,659,476
Proceeds from common stock issued for cash pursuant to Advance Notices					$ 15,173,357
Common stock issued for the repayment of prepaid advance liability and related interest accrual pursuant to Advance Notices ( in shares)					21,798,830
Common stock issued for the repayment of prepaid advance liability and related interest accrual					$ 6,068,407
Common stock value issued for the repayment of prepaid advance liability					5,918,430
Common stock value issued for the repayment of prepaid advance liability					118,619
Loss on debt extinguishment					31,358
Net of cash issuance costs					$ 13,577
Common stock issued for cash pursuant to Advance Notices (in shares)					33,860,646
Gross proceeds from common stock retained to fund operations					$ 9,104,950
Amount of decrease in additional paid in capital					$ 57,030

LEASES - Additional Information

LEASES - Additional Information (Details) - USD ($)			3 Months Ended		6 Months Ended
	Jan. 27, 2024	Jan. 25, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
LEASES
Cash payments due for first three months of the lease					$ 130,838	$ 130,678
Right-of-use asset for lease liability					1,575,919	51,154
Security deposit			$ 5,095		5,095		$ 55,308
Lease liabilities		$ 490,422	1,547,267		1,547,267
Right-of-use asset, net			1,478,413		1,478,413		$ 129,202
Operating lease expense			111,591	$ 65,873	226,708	$ 131,746
Lease agreement for office space in Webster, Texas
LEASES
Lease term (in years)	63 months
Renewal term (in years)	36 months
Monthly rental payments	$ 33,086
Lease base rent	21,950
Common area maintenance fees	11,136
Cash payments due for first three months of the lease	0
Right-of-use asset for lease liability	$ 1,085,497
Incremental borrowing rate (in %)	10%
Security deposit			$ 37,930		$ 37,930
Lease Facility Located At 4863 Shawline Street, San Diego, CA 92111
LEASES
Renewal term (in years)		18 months
Monthly rental payments		$ 29,337
Incremental borrowing rate (in %)		10%
Right-of-use asset, net		$ 490,422

LEASES - Maturities of lease li

LEASES - Maturities of lease liabilities (Details) - USD ($)	Jun. 30, 2024	Jan. 25, 2024	Dec. 31, 2023
LEASES
July 1, 2024 through December 31, 2024	$ 307,722
2025	601,196
2026	280,228
2027	289,008
2028	297,788
Thereafter	101,703
Total future minimum lease payments	1,877,645
Less: amount representing imputed interest	(330,378)
Present value of lease liabilities	1,547,267	$ 490,422
Less: current portion	(487,369)		$ (102,186)
Lease liabilities, non current portion	$ 1,059,898

LEASES - Supplemental cash flow

LEASES - Supplemental cash flow information related to the leases (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows used in operating activities	$ 130,838	$ 130,678
Right-of-use assets obtained in exchange for lease obligations
Operating leases	$ 1,575,919	$ 51,154
Weighted Average Remaining Lease Term (Years)
Operating leases	3 years 9 months 7 days	10 months 17 days
Weighted Average Discount Rate
Operating leases	10%	5%

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
RELATED PARTY TRANSACTIONS
Accounts payable	$ 1,060,694		$ 1,060,694		$ 2,769,544
Chief Technology Officer CTO | Consulting Agreements
RELATED PARTY TRANSACTIONS
Related party expenses	0	$ 16,755	0	$ 27,210
Related Party | Consulting Agreements
RELATED PARTY TRANSACTIONS
Accounts payable	$ 0		$ 0		$ 0

NOTES PAYABLE - Summary of the

NOTES PAYABLE - Summary of the notes payable activity (Details) - USD ($)					3 Months Ended		6 Months Ended
		May 28, 2024	Apr. 29, 2024	Apr. 02, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
NOTES PAYABLE
Net proceeds from notes payable	[1]						$ 1,730,000
Issuance costs paid in cash							(53,200)
Issuance costs to be paid in equity							(112,863)
Underwriting fees paid in cash							(72,900)
Repayments in cash							(1,525,195)
Amortization of debt discount					$ 527,199	$ 214,554	702,276	$ 460,874
Notes payable, current-portion - Notes payable					784,006		784,006
Notes payable, current-portion - Debt discount							(142,261)
Notes payable, current-portion					641,745		641,745
Add: Notes payable, non-current portion - Notes Payable					250,000		250,000
Notes payable, non-current portion					250,000		250,000		$ 250,000
Ending balance of Note Payable gross					1,034,006		1,034,006
Ending balance of Debt Discount					(142,261)		(142,261)
Ending balance of Note Payable net					$ 891,745		891,745
Notes Payable
NOTES PAYABLE
Amortization of debt discount							675,902
Merchant cash advances
NOTES PAYABLE
Proceeds from notes payable gross							1,609,200
Debt discount on notes payable							(529,200)
Net proceeds from notes payable							1,080,000
Promissory Note
NOTES PAYABLE
Proceeds from notes payable gross							700,000
Debt discount on notes payable							(50,000)
Net proceeds from notes payable			$ 200,000	$ 440,000			$ 650,000
Amortization of debt discount		$ 60,000
Notes payable, current-portion - Debt discount				60,000
Ending balance of Note Payable net			$ 200,000	$ 500,000
[1]Face value of $2,309,200, less $579,200 original issue discount.

NOTES PAYABLE (Details)

NOTES PAYABLE (Details) - USD ($)				2 Months Ended
	Jul. 11, 2024	Feb. 26, 2024	Jan. 22, 2024	Nov. 15, 2024
NOTES PAYABLE
Proceeds from cash advance		$ 502,200	$ 504,900
Underwriting fees		37,800	35,100
Finder's fees		21,600	21,600
Total cash advance payable		804,600	804,600
Periodic payments on cash advances	$ 26,820	$ 26,820	$ 25,143.75	$ 15,620
Effective interest rate		249%	217%
If Cash Advance Repaid by March 22, 2024
NOTES PAYABLE
Total cash advance payable		$ 756,000
If Cash Advance Repaid by April 22, 2024
NOTES PAYABLE
Total cash advance payable		$ 783,000

NOTES PAYABLE - Warrants (Detai

NOTES PAYABLE - Warrants (Details) - USD ($)	Jun. 30, 2024	Apr. 04, 2024
Class of Warrant or Right [Line Items]
Grant date fair value of warrants	$ 45,858
Warrants
Class of Warrant or Right [Line Items]
Grant date fair value of warrants		$ 112,863
First Warrant
Class of Warrant or Right [Line Items]
Number of Warrants, Outstanding (in shares)		81,788
Exercise price (in dollars per share)		$ 0.1852
Second Warrant
Class of Warrant or Right [Line Items]
Number of Warrants, Outstanding (in shares)		108,389
Exercise price (in dollars per share)		$ 0.139

NOTES PAYABLE - Fair Value of w

NOTES PAYABLE - Fair Value of warrants (Details)	Jun. 30, 2024 Y
Market price at measurement date
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant measurement input	0.70
Exercise price | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant measurement input	0.14
Exercise price | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant measurement input	0.19
Risk free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant measurement input	4.52
Expected term (years) | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant measurement input	2.8
Expected term (years) | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant measurement input	2.9
Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant measurement input	93

NOTES PAYABLE - Promissory Note

NOTES PAYABLE - Promissory Notes (Details) - USD ($)					3 Months Ended		6 Months Ended
		May 28, 2024	Apr. 29, 2024	Apr. 02, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
NOTES PAYABLE
Initial principal amount					$ 891,745		$ 891,745
Net cash proceeds	[1]						1,730,000
Cash proceeds on discount							(142,261)
Amortization of debt discount					$ 527,199	$ 214,554	702,276	$ 460,874
Promissory Note
NOTES PAYABLE
Initial principal amount			$ 200,000	$ 500,000
Net cash proceeds			$ 200,000	440,000			650,000
Cash proceeds on discount				60,000
Original issuance discount				50,000			$ 579,200
Debt issuance cost				$ 10,000
Annual interest rate (percentage)			16%
Amortization of debt discount		$ 60,000
Promissory Note | Maximum
NOTES PAYABLE
Annual interest rate (percentage)				15%
Principal and cash payment interest rate			16%
Promissory Note | Minimum
NOTES PAYABLE
Annual interest rate (percentage)				0%
Principal and cash payment interest rate			12%
[1]Face value of $2,309,200, less $579,200 original issue discount.

STOCKHOLDERS' EQUITY (DEFICIT_2

STOCKHOLDERS' EQUITY (DEFICIT) - Additional Information (Details)			3 Months Ended			6 Months Ended
	Jan. 26, 2024 USD ($) shares	May 13, 2022 USD ($)	Jun. 30, 2024 USD ($) $ / shares shares	Mar. 31, 2024 USD ($) shares	Mar. 31, 2023 USD ($) shares	Jun. 30, 2024 USD ($) Vote $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Jun. 30, 2023 shares	Dec. 31, 2022 shares
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock, par value (in dollars per share) | $ / shares			$ 0.0001			$ 0.0001	$ 0.0001
Proceeds from common stock issued for cash pursuant to Advance Notices | $			$ 6,194,299	$ 2,910,651
Grant date value of common stock issued related to consulting services provided | $			$ 38,150	$ 6,390	$ 6,820
Preferred stock, shares authorized			20,000,000			20,000,000	20,000,000
Treasury stock, shares			131,162			131,162	131,162
Independent Members of Board of Directors
STOCKHOLDERS' EQUITY (DEFICIT)
Number of shares of common stock issued related to consulting services provided (in shares)						30,000
Grant date value of common stock issued related to consulting services provided | $						$ 17,400
Series A Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, shares authorized			1,000,000			1,000,000	1,000,000
Number of votes per share of preferred stock | Vote						100
Series A Preferred Stock | CEO
STOCKHOLDERS' EQUITY (DEFICIT)
Proceeds from sale of Convertible Preferred Stock and warrants | $	$ 0
Preferred stock, shares authorized	730,000
Series B Convertible Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, shares authorized			31,000			31,000	31,000
Series C Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, shares authorized			400			400	400
Series D Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, shares authorized			650			650	650
Restricted stock awards
STOCKHOLDERS' EQUITY (DEFICIT)
Unrecognized stock-based compensation expense | $			$ 1,134,833			$ 1,134,833
Weighted average remaining vesting period (in years)						10 months 28 days
Stock options
STOCKHOLDERS' EQUITY (DEFICIT)
Unrecognized stock-based compensation expense | $			238,418			$ 238,418
Weighted average remaining vesting period (in years)						2 years 1 month 6 days
Restricted Stock Units
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock issued (in shares)						2,168,508
Unrecognized stock-based compensation expense | $			$ 4,202,362			$ 4,202,362
Weighted average remaining vesting period (in years)						2 years 8 months 4 days
Common Stock
STOCKHOLDERS' EQUITY (DEFICIT)
Number of shares of common stock issued related to consulting services provided (in shares)			74,150	35,500	5,500
Grant date value of common stock issued related to consulting services provided | $			$ 7	$ 4	$ 1
Number of shares issued for common stock (in shares)			70,000	384,627
Common Stock | Legal and consulting services
STOCKHOLDERS' EQUITY (DEFICIT)
Number of shares of common stock issued related to consulting services provided (in shares)						79,650
Grant date value of common stock issued related to consulting services provided | $						$ 27,141
Common Stock | Restricted Stock Units
STOCKHOLDERS' EQUITY (DEFICIT)
Number of shares issued for common stock (in shares)						454,627
Treasury Stock
STOCKHOLDERS' EQUITY (DEFICIT)
Treasury stock, shares			131,162	131,162	131,162	131,162	131,162	131,162	131,162
Treasury stock, value | $			$ 296,222			$ 296,222	$ 296,222
Maximum | Series A Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, shares authorized	1,000,000
Yorkville
STOCKHOLDERS' EQUITY (DEFICIT)
Number of shares issued (in shares)						55,659,476
Proceeds from common stock issued for cash pursuant to Advance Notices | $						$ 15,173,357
Gross proceeds from common stock retained to fund operations | $						$ 9,104,950
SEPA
STOCKHOLDERS' EQUITY (DEFICIT)
Value of shares to be issued | $		$ 50,000,000
Maximum advance value of shares to be issued | $		$ 5,000,000
Price per share to be issued on Market Price (in percent)		98%
Number of consecutive days		3 days
Threshold ownership percentage (in %)		4.99%
SEPA | Yorkville
STOCKHOLDERS' EQUITY (DEFICIT)
Number of shares issued (in shares)						55,659,476
Proceeds from common stock issued for cash pursuant to Advance Notices | $						$ 15,173,357
Gross proceeds from common stock retained to fund operations | $						$ 9,104,950

STOCKHOLDERS' EQUITY (DEFICIT_3

STOCKHOLDERS' EQUITY (DEFICIT) - Summary of warrants activity (Details)	6 Months Ended
	Jun. 30, 2024 USD ($) $ / shares shares
STOCKHOLDERS' EQUITY (DEFICIT)
Number of Warrants, Outstanding at the beginning | shares	2,524,410
Number of Warrants, Issued | shares	190,177
Number of Warrants, Outstanding at the end | shares	2,714,587
Number of Warrants, Exercisable at the end | shares	2,714,587
Weighted Average Exercise Price, Outstanding, Beginning (in dollars per share) | $ / shares	$ 1.02
Weighted Average Exercise Price, Issued (in dollars per share) | $ / shares	0.16
Weighted Average Exercise Price, Outstanding, Ending (in dollars per share) | $ / shares	0.96
Weighted Average Exercise Price, Exercisable at the end (in dollars per share) | $ / shares	$ 0.96
Weighted Average Remaining Term, Outstanding at the end (in years)	1 year 7 months 6 days
Weighted Average Remaining Term, Exercisable at the end (in years)	1 year 7 months 6 days
Intrinsic Value, Outstanding at the end (in dollars) | $	$ 45,858
Intrinsic Value, Exercisable at the end (in dollars) | $	$ 45,858

STOCKHOLDERS' EQUITY (DEFICIT_4

STOCKHOLDERS' EQUITY (DEFICIT) - Outstanding and exercisable warrants (Details) - $ / shares	Jun. 30, 2024	Dec. 31, 2023
STOCKHOLDERS' EQUITY (DEFICIT)
Outstanding Number of Warrants	2,714,587	2,524,410
Exercisable, Weighted Average Remaining Life (in years)	1 year 7 months 6 days
Exercisable, Number of Warrants (in shares)	2,714,587
Exercise Price, $ 1.25
STOCKHOLDERS' EQUITY (DEFICIT)
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.25
Outstanding Number of Warrants	177,885
Exercisable, Weighted Average Remaining Life (in years)	1 year 6 months
Exercisable, Number of Warrants (in shares)	177,885
Exercise Price, $ 1.00
STOCKHOLDERS' EQUITY (DEFICIT)
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1
Outstanding Number of Warrants	2,346,525
Exercisable, Weighted Average Remaining Life (in years)	1 year 6 months
Exercisable, Number of Warrants (in shares)	2,346,525
Exercise Price, $ 0.19
STOCKHOLDERS' EQUITY (DEFICIT)
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.19
Outstanding Number of Warrants	81,788
Exercisable, Weighted Average Remaining Life (in years)	2 years 7 months 6 days
Exercisable, Number of Warrants (in shares)	81,788
Exercise Price, $ 0.14
STOCKHOLDERS' EQUITY (DEFICIT)
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.14
Outstanding Number of Warrants	108,389
Exercisable, Weighted Average Remaining Life (in years)	2 years 8 months 12 days
Exercisable, Number of Warrants (in shares)	108,389

STOCKHOLDERS' EQUITY (DEFICIT_5

STOCKHOLDERS' EQUITY (DEFICIT) - Summary of options activity (Details)	6 Months Ended
	Jun. 30, 2024 USD ($) $ / shares shares
STOCKHOLDERS' EQUITY (DEFICIT)
Number of Options, Outstanding | shares	722,716
Number of Options, Granted | shares	55,000
Number of Options, Forfeited | shares	(75,000)
Number of Options, Outstanding | shares	702,716
Number of Options, Exercisable | shares	357,715
Weighted Average Exercise Price, Outstanding | $ / shares	$ 1.26
Weighted Average Exercise Price, Granted | $ / shares	0.27
Weighted Average Exercise Price, Forfeited | $ / shares	0.89
Weighted Average Exercise Price Outstanding | $ / shares	1.22
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.84
Weighted Average Remaining Term, Outstanding	2 years 6 months
Weighted Average Remaining Term, Exercisable	1 year 2 months 12 days
Number of Options Intrinsic Value, Outstanding | $	$ 7,328

STOCKHOLDERS' EQUITY (DEFICIT_6

STOCKHOLDERS' EQUITY (DEFICIT) - Options outstanding and exercisable related to stock options (Details) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
STOCKHOLDERS' EQUITY (DEFICIT)
Options Outstanding, Exercise Price	$ 0.84		$ 0.84
Options Outstanding, Number of Options	702,716		702,716		722,716
Options Exercisable, Weighted Average Remaining Term (In Years)			1 year 2 months 12 days
Options Exercisable Number of Options	357,715		357,715
Weighted average grant date fair value	$ 0.21	$ 0.48	$ 0.20	$ 0.74
$0.19 - $0.99
STOCKHOLDERS' EQUITY (DEFICIT)
Options Outstanding, Number of Options	322,986		322,986
Options Exercisable, Weighted Average Remaining Term (In Years)			4 months 24 days
Options Exercisable Number of Options	201,735		201,735
$0.19 - $0.99 | Minimum
STOCKHOLDERS' EQUITY (DEFICIT)
Options Outstanding, Exercise Price	$ 0.19		$ 0.19
$0.19 - $0.99 | Maximum
STOCKHOLDERS' EQUITY (DEFICIT)
Options Outstanding, Exercise Price	$ 0.99		$ 0.99
$1.21 - $1.50
STOCKHOLDERS' EQUITY (DEFICIT)
Options Outstanding, Number of Options	145,000		145,000
Options Exercisable, Weighted Average Remaining Term (In Years)			3 years 6 months
Options Exercisable Number of Options	36,250		36,250
$1.21 - $1.50 | Minimum
STOCKHOLDERS' EQUITY (DEFICIT)
Options Outstanding, Exercise Price	$ 1.21		$ 1.21
$1.21 - $1.50 | Maximum
STOCKHOLDERS' EQUITY (DEFICIT)
Options Outstanding, Exercise Price	$ 1.50		$ 1.50
$1.55 - $1.99
STOCKHOLDERS' EQUITY (DEFICIT)
Options Outstanding, Number of Options	80,000		80,000
Options Exercisable, Weighted Average Remaining Term (In Years)			2 years 9 months 18 days
Options Exercisable Number of Options	30,000		30,000
$1.55 - $1.99 | Minimum
STOCKHOLDERS' EQUITY (DEFICIT)
Options Outstanding, Exercise Price	$ 1.55		$ 1.55
$1.55 - $1.99 | Maximum
STOCKHOLDERS' EQUITY (DEFICIT)
Options Outstanding, Exercise Price	$ 1.99		$ 1.99
$2.05 - $2.44
STOCKHOLDERS' EQUITY (DEFICIT)
Options Outstanding, Number of Options	154,730		154,730
Options Exercisable, Weighted Average Remaining Term (In Years)			2 years 6 months
Options Exercisable Number of Options	89,730		89,730
$2.05 - $2.44 | Minimum
STOCKHOLDERS' EQUITY (DEFICIT)
Options Outstanding, Exercise Price	$ 2.05		$ 2.05
$2.05 - $2.44 | Maximum
STOCKHOLDERS' EQUITY (DEFICIT)
Options Outstanding, Exercise Price	$ 2.44		$ 2.44

STOCKHOLDERS' EQUITY (DEFICIT_7

STOCKHOLDERS' EQUITY (DEFICIT) - Fair value of stock options granted using the Black-Scholes options (Details) - Stock options	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
STOCKHOLDERS' EQUITY (DEFICIT)
Expected term (years)	3 years 9 months 18 days	3 years 6 months		3 years 6 months
Expected volatility	110%	107%
Expected dividends	0%	0%		0%
Minimum
STOCKHOLDERS' EQUITY (DEFICIT)
Risk free interest rate	4.75%	4.07%	4.27%	3.92%
Expected volatility			110%	105%
Maximum
STOCKHOLDERS' EQUITY (DEFICIT)
Risk free interest rate	4.81%	4.52%	4.81%	4.52%
Expected volatility			114%	107%

STOCKHOLDERS' EQUITY (DEFICIT_8

STOCKHOLDERS' EQUITY (DEFICIT) - Restricted stock awards and restricted stock units (Details)	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Restricted stock awards
Shares of Restricted Common Stock/ Number of Restricted Common Units
Beginning balance (in shares) | shares	3,381,008
RSAs exchanged for RSUs (in shares) | shares	(2,168,508)
Vested (in shares) | shares	(562,500)
Ending balance (in shares) | shares	650,000
Weighted Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share) | $ / shares	$ 1.53
RSAs exchanged for RSUs (in dollars per share) | $ / shares	0.94
Vested (in dollars per share) | $ / shares	2.60
Ending balance (in dollars per share) | $ / shares	$ 2.53
Unvested restricted stock units
Shares of Restricted Common Stock/ Number of Restricted Common Units
Beginning balance (in shares) | shares	2,250,000
RSAs exchanged for RSUs (in shares) | shares	2,168,508
Granted (in shares) | shares	851,230
Vested (in shares) | shares	(454,627)
Ending balance (in shares) | shares	4,815,111
Weighted Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share) | $ / shares	$ 2.05
RSAs exchanged for RSUs (in dollars per share) | $ / shares	0.94
Granted (in dollars per share) | $ / shares	0.38
Vested (in dollars per share) | $ / shares	0.94
Ending balance (in dollars per share) | $ / shares	$ 1.36

STOCKHOLDERS' (DEFICIT) EQUITY

STOCKHOLDERS' (DEFICIT) EQUITY - Stock-Based Compensation (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
STOCKHOLDERS' EQUITY (DEFICIT)
Stock-based compensation expense	$ 909,026	$ 964,201	$ 1,754,955	$ 1,884,356
Stock-based compensation			1,754,955	1,966,929
Selling, general and administrative expenses
STOCKHOLDERS' EQUITY (DEFICIT)
Stock-based compensation expense	870,837	927,375	1,678,942	1,831,370
Research and development expenses
STOCKHOLDERS' EQUITY (DEFICIT)
Stock-based compensation expense	38,189	36,826	76,013	52,986
Common stock for services (includes accrued, unissued shares)
STOCKHOLDERS' EQUITY (DEFICIT)
Stock-based compensation expense	65,523	96,350	97,915	210,800
Stock options
STOCKHOLDERS' EQUITY (DEFICIT)
Stock-based compensation expense	29,165	44,311	61,206	84,916
Restricted stock awards and units
STOCKHOLDERS' EQUITY (DEFICIT)
Stock-based compensation expense	$ 814,338	$ 823,540	$ 1,595,834	$ 1,588,640

SUBSEQUENT EVENTS - At the mark

SUBSEQUENT EVENTS - At the market offering (Details) - USD ($)		1 Months Ended	3 Months Ended
	Jul. 03, 2024	Aug. 09, 2024	Jun. 30, 2024	Mar. 31, 2024
SUBSEQUENT EVENTS
Aggregate proceeds			$ 6,194,299	$ 2,910,651
Subsequent event | ATM
SUBSEQUENT EVENTS
Maximum aggregate offering price	$ 20,000,000
Commission paid to agent as a percentage of gross proceeds (in percent)	3%
Common stock issued (in shares)		4,953,867
Aggregate proceeds		$ 1,416,940

SUBSEQUENT EVENTS - Merchant Ca

SUBSEQUENT EVENTS - Merchant Cash Advance (Details) - USD ($)				2 Months Ended
	Jul. 11, 2024	Feb. 26, 2024	Jan. 22, 2024	Nov. 15, 2024
SUBSEQUENT EVENTS
Proceeds from cash advance		$ 502,200	$ 504,900
Underwriting fees		37,800	35,100
Total cash advance payable		804,600	804,600
Periodic payments on cash advances	$ 26,820	$ 26,820	$ 25,143.75	$ 15,620
Subsequent event
SUBSEQUENT EVENTS
Proceeds from cash advance	758,850
Underwriting fees	40,000
Payment of remaining balance of first merchant cash advance	201,150
Total cash advance payable	1,350,000
Periodic payments on cash advances	31,395
Periodic payments on cash advances after amendment	15,620
Subsequent event | If cash advance repaid by August 11 2024
SUBSEQUENT EVENTS
Total cash advance payable	1,230,000
Subsequent event | If cash advance repaid by September 11 2024
SUBSEQUENT EVENTS
Total cash advance payable	$ 1,310,000